| 製品/価格一覧 |
|
|
|
|
|
|
|
|
|
|
|
|
| 詳細は下記URLに記載のIFUをご参照ください。 |
|
|
| http://www.drg-international.com/servlet/public/catalog/DRG.html |
|
|
|
|
|
2011.1.1改定 |
| Product |
Cat. # |
Incubation |
Stand. Range / Sensitivity |
Specimen |
Test Type |
Test Meth. |
Units |
Price(円) |
| A |
|
|
|
|
|
|
|
|
| Acetylchloline
Receptor (AChR) Ab Elisa |
EIA4936 |
overnight 2-8C, 60/60/30/30 min
RT |
0.5- 20 nmol/l /// 0.23 nmol./l |
100 ul serum |
quantitative |
MTPL |
96 wells |
339,000 |
| ACPA
(Anti-Citrullinated Protein Ab) (Anti-MCV) Elisa |
EIA4848 |
30 / 15 / 15 min |
10 - 500 U/ml /// 2 U/mo |
10 ul serum, plasma |
quantitative |
MTPL |
96 wells |
111,000 |
| ACTH
(Adrenocorticotropic Hormone) |
EIA3647 |
4 hrs |
.46pg/mL |
human serum |
quantitative |
MTPL |
96 wells |
101,000 |
| Adenovirus
IgA |
EIA3445 |
60min 37C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
65,000 |
| Adenovirus
IgG |
EIA3446 |
60 min. 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
65,000 |
| Adenovirus
IgM |
EIA3447 |
60 min. 37 C; 15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Adenovirus-FL&K87
(mouse) EcoElisa |
EIA4946 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Adenovirus-FL&K87
(mouse) EcoElisa |
EIA4947 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Adenovirus-FL&K87
(rat) EcoElisa |
EIA4948 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Adenovirus-FL&K87
(rat) EcoElisa |
EIA4949 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Adipocyte
FABP (AFABP, FABP4) human Elisa |
EIA4908 |
60 / 60 / 30 / 10 min |
0.5 - 25 ng/ml /// <0.1 ng/ml |
20 ul serum, plasma |
quantitative |
MTPL |
96 wells |
415,000 |
| Adiponectin
(human) Elisa |
EIA4177 |
120/30/5-10 min |
1.56 - 200 ng/ml // 0.78 ng/ml |
20 ul serum, plasma, tissues
culture media or e |
quantitative |
MTPL |
96 wells |
244,000 |
| Adiponectin
(human) Elisa |
EIA4574 |
120 / 10 min |
0.1 - 10 ug/ml // 7 ng/ml |
10 ul serum / plasma |
quantitative |
MTPL |
96 wells |
282,000 |
| Adiponectin
(human) Elisa |
EIA4646 |
60 / 60 / 15 min |
5 - 300 ng/ml /// 1.25 ng/ml |
25 ul serum / plasma |
quantitative |
MTPL |
96 wells |
306,000 |
| Adiponectin
(human) Elisa |
EIA4820 |
90 / 30 / 20 min |
1.56 - 100 ng/ml /// <3 ng/ml |
5-10 ul cell culture
supernatants, plasma and s |
quantitative |
MTLP |
96 wells |
168,000 |
| Adiponectin
(human) high molecular weight (HMW) |
EIA4645 |
120/60/30/5-20 min (sample prep
2h, 20 min) |
1.56 ng/ml to 200 ng/ml /// 0.5 ng/ml |
20 ul serum, plasma, and
adipocyte extracts or |
quantitative |
MTPL |
96 wells |
295,000 |
| Adiponectin
(mouse) Elisa |
EIA4172 |
120/30/15 min |
0.78 - 100 ng/ml // 0.5 ng/ml |
10 ul serum, plasma, tissue
culture media (dilu |
quantitative |
MTPL |
96 wells |
244,000 |
| Adiponectin
Rat Elisa |
EIA4570 |
120 / 60 / 30 / 5 - 25 min |
3.125- 200 ng/ml // 0.155 ng/ml |
20 ul serum, plasma, nd
adipocyte extracts or c |
quantitative |
MTPL |
96 wells |
244,000 |
| Adrenalin
Research Elisa |
EIA4776 |
Acylation: 55 min, EIA: 30/120/30 min |
5 - 1280 pg/sample // 1.7 pg/sample |
1-100 ul, tissues extracts,
dialysates, small a |
quantitative |
MTPL |
96 wells |
228,000 |
| Adrenaline
(Epinephrine) |
EIA1908 |
14-20 h/120/40 min. |
1,4-150 ng/ml |
75 ul urine/ Extr. &
Acylat. EXTRACTION POSSIB |
quantitative |
MTPL |
96 wells |
190,000 |
| Adrenaline
/ Noradrenaline (Cat Combi Elisa) |
EIA4309 |
3.5 hours |
Epinephrine 1-256ng/ml,
Norepinephrine 0/1-1,024ng |
plasma and urine |
quantitative |
MTPL |
2 x 96 wells |
285,000 |
| Adrenaline
/ Noradrenaline (Cat Combi Research Elisa) |
EIA4892 |
90 min Aculation 2h 37C/15-20 h
2-8C/20-30min |
0.45 - 45 ng/ml /// 0.3/02 ng/ml |
1-750 uL; for various biological
sample types a |
quantitative |
MTPL |
2x96 wells |
322,000 |
| Adrenaline
/ Noradrenaline (Catcombi Elisa) |
EIA3175 |
120/90/15 min. at RT |
Adrenatlin: 1.5 - 150 ul/ml,
Noradrenalin: 5 - 500 |
10 ul extracted plasma or urine |
quantitative |
MTPL |
2 x 96 wells |
249,000 |
| Adrenaline
Elisa |
EIA4306 |
30 / 120 / 30 / 10-30 min |
1-256 pg/ml 0.33 ng/mL urine / 11 pg/mL plasma |
10ul urine / 300 ul plasma |
quantitative |
MTPL |
96 wells |
204,000 |
| Adrenaline/Noradrenaline
(Cat Combi <plasma>) ultra sensitive |
EIA5131 |
96 min Acylation/ 2h 37C/15-20 h
2-8C / 30/20-30 min. |
A: 15-1500 pg/ml N: 60-6000 pg/ml |
750 uL plasma |
quantitative |
MTPL |
2 x 96 wells |
261,000 |
| Adrenomedullin,
(human) (1-52) |
EIA3418 |
|
|
|
quantitative |
MTPL |
96 wells |
177,000 |
| Adrenomedullin,
(Pro-) N20 (PAMP-20) (human) |
EIA3419 |
|
|
|
quantitative |
MTPL |
96 wells |
177,000 |
| Afamin
Elisa |
EIA5085 |
1/1 hr 20 min |
??? mg/L /// 0.01 mg/L |
serum / plasma |
quantitative |
MTPL |
96 wells |
198,000 |
| AFP
(Alpha Fetoprotein) |
EIA1468 |
40 min. at RT |
10-160 ng/ml |
serum, amino fluid |
quantitative |
MTPL |
96 wells |
63,000 |
| AFP
(Alpha Fetoprotein) - extended Standard Range |
EIA4331 |
1 hr. at RT |
2.0 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
65,000 |
| Akt
(total), (human, mouse, rat) |
EIA3996 |
120/60/30/30 min |
0.3 - 20 ng/ml / 0.1 ng/ml |
100 ul cell extract |
quantitative |
MTPL |
96 tests |
394,000 |
| Akt
[pS473], (human, mouse, rat) |
EIA3997 |
120/60/30/30 min |
1.6 - 100 U/ml / 0.8U/ml |
100 ul cell extract |
quantitative |
MTPL |
96 tests |
394,000 |
| Aldosterone |
CLA4650 |
60 / 10 min |
20 - 2000 pg/m // 10 pg/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
82,000 |
| Aldosterone
Elisa |
EIA4410 |
60 min. 37C / 30 min. RT |
20 - 2000 pg/ml // 15 pg/ml |
50 ul serum / plasma |
quantitative |
MTPL |
96 wells |
88,000 |
| Aldosterone
Elisa |
EIA4600 |
60/10-15 min |
20-2000 pg/ml // 15 pg/ml |
50 ul serum + urine |
quantitative |
MTPL |
96 wells |
78,000 |
| Aldosterone,
direct (order urine diluent at
the time of order if needed) |
EIA4128 |
60/20 min |
15 - 1000 pg/ml // 10 pg/ml |
50 ul serum or diluted urine |
quantitative |
MTPL |
96 wells |
76,000 |
| AMA-M2 Elisa |
EIA3604 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| Amylase
Elisa |
EIA4460 |
30 / 15 min |
10 - 300 U/L // 6 U/L |
10 uL serum |
quantitative |
MTPL |
96 wells |
76,000 |
| Amylase,
Alpha Amylase Saliva |
ENZ5127 |
3 min 37 C |
0-400 U/ml /// 2.5 U/ml |
10 ul saliva |
quantitative |
MTPL |
96wells |
80,000 |
| Amylin
(total) Elisa |
EIA3741 |
10 min. at RT/ 1h at RT shaking/
2h at RT shaking/ 20 mi |
0-100pM / 1 pM |
50 ul plasma |
quantitative |
MTPL |
96 wells |
194,000 |
| Amylin
Elisa (Fluorescence Plate Reader needed to run this kit) |
EIA3742 |
10 min. at RT/ 1h at RT shaking/
2h at RT shaking/ 20min |
0-100pM / 1pM |
50 ul plasma |
quantitative |
MTPL |
96 wells |
202,000 |
| Amyloid
beta 1-40 (colometric) |
COL3994 |
6.5 h |
|
|
quantitative |
COLO |
96 tests |
434,000 |
| Amyloid
beta 1-42 (colometric) |
COL3995 |
6.5 h |
|
|
quantitative |
COLO |
96 tests |
434,000 |
| Amyloid
Beta Auto-Ab (serum) Elisa |
EIA5099 |
60 / 60/ 30 min |
1 - 120 RTU /// <1 RTU |
20 ul serum |
quantitative |
MTPL |
96 wells |
289,000 |
| ANA
(Anti-Nuclear Antibodies) |
EIA4830 |
20/20/10 min. |
... /// 95 % |
10 ul serum |
quantitative |
MTPL |
96 wells |
95,000 |
| ANA
Screen Blot (8 strips = unit) |
DOT5114 |
5 / 60 / 30 / 10 min |
on strip |
10ul serum |
strip |
Immunoblot |
8 strips |
78,000 |
| ANA
Screen Blot (16 strips - unit) |
DOT5113 |
5/60/30/10 min |
on strip |
10 ul serum |
strip |
Immunoblot |
16 strips |
111,000 |
| ANA
Screen IgG (anti-nuclear antibodies) |
EIA2773 |
60, 30, 30 RT |
|
serum, 10 uL |
qualitative |
MTPL |
96 wells |
78,000 |
| ANA-8-Profile
Elisa |
EIA3563 |
|
|
|
quantitative |
MTPL |
96 wells |
92,000 |
| ANA-8-Profile
Elisa |
EIA4325 |
30 / 30 / 30 min. RT |
neg., pos. control // <0.2 |
10 ul serum (diluted 1/100) |
qualitative |
MTPL |
96 wells |
92,000 |
| ANA-8-Screen
Elisa |
EIA3562 |
|
|
|
quantitative |
MTPL |
96 wells |
92,000 |
| ANCA
(cANCA) anti-PR3 |
EIA3596 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| ANCA
combi "ANCA Profil"
Elisa |
EIA3595 |
|
|
|
quantitative |
MTPL |
96 wells |
133,000 |
| ANCA
Screen Blot (16 strips = unit) |
DOT5116 |
5 / 60/ 30 / 10 min |
on strip |
10 ul serum |
strips |
Immunoblot |
16 strips |
111,000 |
| ANCA
Screen Blot (8 strips = unit) |
DOT5115 |
5 / 60 / 30 / 10 min |
on strip |
10 ul serum |
strip |
Immunoblot |
8 strips |
78,000 |
| ANCA
Screen Elisa |
EIA3776 |
30'/15'/15' RT |
qualitative, cut-off control |
serum or plasma 10 ul |
qualitative |
MTPL |
96 wells |
122,000 |
| ANCA
Screen IgG |
EIA2777 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
MTPL |
96 wells |
78,000 |
| Androstane,
5a-Androstane-3a, 17beta-diol Glucuronide (3a Diol G) |
EIA4192 |
30/15 min |
0.25 - 50 ng/ml // 0,1 ng/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
82,000 |
| Androstenedione
Elisa |
EIA3265 |
|
|
|
|
|
96 wells |
67,000 |
| Androstenedione
Saliva |
EIA4347 |
60 / 15 min. |
5 - 1000 pg/ml // 1pg/ml |
100 ul Saliva |
quantitative |
MTPL |
96 wells |
73,000 |
| Androstenedione
Saliva Elisa |
SLV4780 |
60 / 15 min |
20 - 1000 pg/mL /// 5 pg/mL |
50 uL Saliva |
quantitative |
MTPL |
96 wells |
88,000 |
| Angiotensin
1 |
EIA1638 |
4 hrs. at RT |
0.1 ng/ml |
plasma |
quantitative |
MTPL |
96 wells |
177,000 |
| Angiotensin
2 |
EIA1526 |
|
0.2ng/mL |
|
quantitative |
MTPL |
96 wells |
177,000 |
| Animal
Insulin Control (3 vials /ea.0.5ml)<low,medium, high> |
CTL4784 |
|
|
|
controls |
|
1 vial |
78,000 |
| Annexin
V (human) Elis |
EIA5208 |
120 / 60 / 10 min |
0.8 - 50 ng/ml /// 0.33 ng/ml |
50 ul cell culture supernatant,
serum |
|
|
96 wells |
217,000 |
| Annexin
V IgG/IgM, anti- |
EIA3971 |
13'/15'/15' RT |
6.3 - 100 U/ml // 1 U/ml |
10 ul serum or plasma |
quantitative |
MTPL |
96 wells |
130,000 |
| ANP,
alpha- (human) (Atrial Natriuretic Polypeptide ) |
EIA1524 |
|
0.2 ng/mL |
|
quantitative |
MTPL |
96 wells |
177,000 |
| Anti-Intrinsic
Factor Elisa |
EIA4392 |
30 / 15 / 15 min. |
6.3 - 100 U/mll // 1 U/ml |
10 ul serum / plasma |
quantitative |
MTPL |
96 wells |
124,000 |
| Apelin-C
Terminus (human/mouse/rat) Elisa |
EIA5178 |
150/45/30 min |
0.01-1000 pg/ml /// 29.1 pg/ml |
50 ul serum/plasma, cell culture
medium or urin |
quantitative |
MTPL |
96 wells |
177,000 |
| APO A
(Apolipoprotein) |
EIA1907 |
60/15 min. |
0.36-6.0 U/L |
25 ul serum |
quantitative |
MTPL |
96 wells |
219,000 |
| ASCA IgG, Elisa |
EIA4280 |
60 / 30 min. 37 C, 10 min RT |
20 - 300 U/ml // 10 U/ml |
10 ul serum (1:51 diluted) |
quantitative |
MTPL |
96 wells |
120,000 |
| ASCA
combi Elisa |
EIA4278 |
60 / 30 min. 37 C, 10 min RT |
no qualitative eval. (compare w.
pos. control) // |
10 ul serum (1:51 diluted) |
qualitative |
MTPL |
96 wells |
113,000 |
| ASCA
IgA Elisa |
EIA4279 |
60 / 30 min. 37 C, 10 min RT |
20-300 U/ml // 10 U/ml |
10 ul serum (1:51 diluted) |
quantitative |
MTPL |
96 wells |
113,000 |
| ASGPR -
Anti-ASGPR Elisa |
EIA4271 |
60 / 30 min. 37 C, 10 min RT |
pos. / neg. and cut off
control // 0.3 (ratio) |
10 ul serum, plasma (1:51
diluted) |
qualitaitve |
MTPL |
96 wells |
149,000 |
| Aspergillus
fumigatus IgA |
EIA2500 |
|
|
|
|
|
96 wells |
128,000 |
| Aspergillus
fumigatus IgG |
EIA2501 |
60/30/20 min |
1-200 U/mL // / |
5 ul serum, plasma |
quantitative |
MTPL |
96 wells |
128,000 |
| Aspergillus
fumigatus IgM |
EIA2502 |
|
|
|
|
|
96 wells |
128,000 |
| Astrovirus
Ag (stool) Elisa |
EIA4456 |
60/10 min |
pos./neg. control // 96% |
stool specimen |
qualitative |
MTPL |
96 wells |
111,000 |
| Avian
Influenza A Nucleoprotein Ag Capture |
EIA4711 |
30/45/10 min on plate shaker |
pos + neg control /// <90%- /// <89% |
200 ul of complex sample
matrices derived from |
qualitative |
MTPL |
2 x 96 wells |
168,000 |
| Avian
Influenza A Nucleoprotein Ag Capture |
EIA4713 |
30/45/10 min on plae shaker |
pos + neg control /// <90% |
200 ul of complex sample
matrices derived from |
qualitative |
MTPL |
5 x 96 wells |
318,000 |
| Avian
Leukosis Virus-p27 antigen |
EIA2499 |
120/60/15 min. |
Positive and Negative Control |
100 ul egg or serum (1:1
diluted) |
|
VET. |
96 wells |
124,000 |
| B |
|
|
|
| BLV
(Bovine Leukemea Virus) p24 blockin AB, MCA based |
EIA3159 |
|
|
|
|
VET. |
96 wells |
116,000 |
| BLV
(Bovine Leukemia Virus) p24/gp51 antibodies (milk) |
EIA2496 |
90/90/90/15 min. |
Positive and Negative Control |
100 ul milk (undiluted) |
|
VET. |
96 wells |
109,000 |
| BLV
(Bovine Leukemia Virus) p24/gp51 antibodies (serum) |
EIA2495 |
90/90/60/15 min. |
Positive and Negative Control |
100 ul Serum (1:20 diluted) |
|
VET. |
96 wells |
109,000 |
| BNP-32,
(rat) (Brain Natriuretic Peptide) EIA |
EIA3428 |
|
|
|
quantitative |
MTPL |
96 wells |
177,000 |
| Bordetella
pertussis IgA / toxin |
EIA3449 |
60min. 37 C; 15 RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| Bordetella
pertussis IgG / toxin |
EIA3450 |
60 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| Bordetella
pertussis IgM / toxin |
EIA3451 |
60min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
78,000 |
| Borrelia
Blot IgG, (anti-Borrelia) |
DOT4539 |
5/45/3x5/45/3x5 min RT |
- (comparison
with charge specific Blot pattern)
// |
20 ul serum (1:100 diluted) |
Blot strips |
Immunoblot |
27 tests |
109,000 |
| Borrelia
Blot IgM (anti-Borrelia) |
DOT4540 |
5/45/3x5/45/3x5 min RT |
- (comparison
with charge specific Blot pattern)
// |
20 ul serum (1:100 diluted) |
strips |
Immunoblot |
27 tests |
111,000 |
| Borrelia
burgdorferi Canine Ab Elisa |
EIA4794 |
|
neg. / pos. control |
serum and plasma |
qualitative |
VET. |
96 wells |
175,000 |
| Borrelia
burgdorferi IgG (Lyme) ( ref. sera opt., price on req.) |
EIA2810 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
MTPL |
96 wells |
80,000 |
| Borrelia
burgdorferi IgG Elisa |
EIA4486 |
30/30 min 37 C / 15 min RT |
pos. / neg. control // 95 % |
10 ul serum |
qualitative |
MTPL |
96 wells |
99,000 |
| Borrelia
burgdorferi IgG/IgM (Lyme ) (ref. sera opt., price on req.) |
EIA2809 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
MTPL |
96 wells |
80,000 |
| Borrelia
burgdorferi IgM (Lyme ) (ref. sera opt., price on req.) |
EIA2811 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
MTPL |
96 wells |
80,000 |
| Borrelia
burgdorferi IgM Elisa |
EIA4485 |
30/30 min 37C / 15 min. RT |
pos. / neg control / 90 % |
10 ul serum |
qualitative |
MTPL |
96 wells |
99,000 |
| Borrelia
IgG Elisa (recombinant) |
EIA4289 |
60/30 37 C; 30 min. RT |
pos. / neg, cut-off control |
10 ul serum (diluted 1:101) |
qualitative |
MTPL |
96 wells |
113,000 |
| Borrelia
IgM Elisa (recombinant) |
EIA4288 |
60/30 37 C; 30 min RT |
pos. / neg cut-off control |
10 ul serum (diluted 1:101) |
qualitative |
MTPL |
96 wells |
113,000 |
| BPI,
anti- Elisa |
EIA3598 |
|
|
|
quantitative |
MTPL |
96 wells |
151,000 |
| Bradykinin
(human - rat - mouse) |
EIA1639 |
4 hrs. at RT |
0.05 ng/ml |
plasma |
quantitative |
MTPL |
96 wells |
177,000 |
| Brucella
Ab, cattle |
EIA2497 |
|
Positive and Negative Control |
|
|
VET. |
96 wells |
113,000 |
| Brucella
IgA (human)
min. order 5 kits |
EIA3271 |
60/30/20 min. at RT |
1 - 200 U/ml |
100 ul serum, plasma (1:100
diluted) |
quantitative |
MTPL |
96 wells |
128,000 |
| Brucella
IgG |
EIA3455 |
60 min 37C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Brucella
IgM |
EIA3456 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Buprenorphine (must req. ctrls. when ord. for either
serum, plasma, blood) |
EIA1498 |
45 min. at RT |
n/a |
serum, plasma, blood |
quantitative |
MTPL |
96 wells |
107,000 |
| C |
|
|
|
| C1q CIC
Elisa |
EIA3169 |
30/30/15 min. at 37 C |
2 Standards ( high/low),
concentration : 16y/ml an |
100 ul diluted Serum, Plasma |
quantitative |
MTPL |
96 wells |
88,000 |
| C3bi
CIC |
EIA3990 |
30/30/15 min |
0-64 ug/ml / 2ug/ml |
10 ul serum |
quantitative |
MTPL |
96 wells |
88,000 |
| C3d CIC
Elisa |
EIA3170 |
30/30/15 min. at 37 C |
2 Standards (high/low), human
aggregate IgG, |
100 ul diluted Serum, Plasma |
quantitative |
MTPL |
96 wells |
88,000 |
| C3d
Elisa |
EIA2333 |
30/15/15 min. |
2 standards ( low and high) 2
controls |
100 ul serum (1:5 diluted) |
|
|
96 wells |
204,000 |
| C5a
(Anaphylatoxin/Complement Component) EIA |
EIA3327 |
20/15 min. at 37 C/ min. at RT |
Standard range: 0.1 - 10ug/L |
human plasma or urine |
quantitative |
MTPL |
192 wells |
158,000 |
| CA 125 |
EIA3939 |
50 / 30 min |
15 - 200 U/ml // 3.327 U/ml |
50 ul serum, plasma |
quantitative |
MTPL |
96 wells |
73,000 |
| CA 125
(Ovarian Cancer) Antigen |
EIA1472 |
3 hrs. at 37 C. |
5 U/ml |
serum |
quantitative |
MTPL |
96 wells |
78,000 |
| CA 15-3 |
EIA3941 |
60/30/30 min |
25-200 U/ml // 0.905 U/ml |
10 ul serum, plasma |
quantitative |
MTPL |
96 wells |
73,000 |
| CA 15-3
(Breast Cancer) Antigen (BCA) |
EIA1473 |
120 min. at 37 C. |
5 U/ml |
serum |
quantitative |
MTPL |
96 wells |
82,000 |
| CA 19-9 |
EIA3940 |
30 / 30 min |
15-240 U/ml / 0.888 U/ml |
10 ul serum, plasma |
quantitative |
MTPL |
96 wells |
73,000 |
| CA 19-9
(Gastrointestinal Cancer) Antigen (GCA) |
EIA1474 |
120 min. at 37 C. |
5 U/ml |
serum |
quantitative |
MTPL |
96 wells |
78,000 |
| CA 72-4 |
CLA4730 |
|
|
|
quantitative |
MTPL |
96 wells |
132,000 |
| CA 72-4 |
EIA3942 |
120/30 min. |
3-100 U/ml // < 0.311 |
20 ul serum, plasma |
quantitative |
MTPL |
96 wells |
73,000 |
| CA-242
Elisa - Pancreatic-colo-rectal -
(no controls incuded) |
EIA4581 |
120 / 60 / 30 min. |
5 - 200 U/ml // 1 U/ml |
25 ul serum |
quantitative |
MTPL |
96 wells |
116,000 |
| CagA |
EIA4138 |
60/30/15 min |
0-240 RU/ml //sensit. vs Western Blot: 93.7
% |
100 ul serum (1:300 diluted) |
qualitative |
MTPL |
96 wells |
94,000 |
| Calcitonin |
EIA3648 |
4 hrs |
1 pg / mL |
human serum |
quantitative |
MTPL |
96 wells |
95,000 |
| Calcitonin
(salmon) |
EIA1636 |
4 hrs. at RT |
0.2 ng/ml |
plasma |
quantitative |
MTPL |
96 wells |
177,000 |
| Calcitonin
Gene Related Peptide (CGRP)(Human) - EIA Kit |
EIA4513 |
2h / 1h/ 1h RT |
0 - 100 ng/ml // 0.23 ng/ml |
50 ul plasma |
quantitative |
MTPL |
96 wells |
177,000 |
| Calprotectin
(MRP 8/14) Blood/Urine Elisa |
EIA5111 |
3 x 1h 37C, 10-20 min. RT |
3.9 - 250 ng/ml /// 3.2 ng/ml |
100 ul serum, plasma, urine
(diluted 1:10- 1:50 |
quantitative |
MTPL |
96 wells |
274,000 |
| Calprotectin
(MRP 8/14) Elisa |
EIA4498 |
60/60/60 37C / 10-20 min RT |
3.9 250 ng/ml // 2.9 ng/ml |
100 ul serum ( 1:50 dil.); urine
(1:10 dil.); 1 |
quantitative |
MTPL |
96 wells |
308,000 |
| Calprotectin
(MRP 8/14) Stool (2h) Elisa |
EIA5190 |
60/60 min. 37 C, 10-20 min. RT |
13-840 ng/ml /// 2.8 ng/ml |
abt. 80 - 120 mg stool samples |
quantitative |
MTPL |
96 wells |
263,000 |
| Candida
albicans IgA |
EIA3457 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative/semi-qua |
MTPL |
96 wells |
65,000 |
| Candida
albicans IgG |
EIA3458 |
60 min 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
65,000 |
| Candida
albicans IgM |
EIA3459 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| Carbacillu
(rat) EcoElisa |
EIA4950 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Carbacillu
(rat) EcoElisa |
EIA4951 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Carbonylprotein
Elisa |
EIA5141 |
3hrs 37C; 20/20/20 min RT |
156 - 2500 pmol/mg /// 20 pmol/mg |
4 uL biolog. samples such as
EDTA-plasma, bronc |
quantitative |
MTPL |
96 wells |
255,000 |
| Cardiolipin
IgA (ref. sera optional, price on req.) |
EIA2790 |
20, 20, 10 RT. |
|
serum, 10uL |
semi-quant. |
MTPL |
96 wells |
82,000 |
| Cardiolipin
IgG (ref. sera optional, price on req.) |
EIA2788 |
20, 20, 10 RT |
|
serum, 10uL |
semi-quant. |
MTPL |
96 wells |
80,000 |
| Cardiolipin
IgG/IgM anti- Elisa |
EIA3587 |
60' RT |
igG:0-120 GPL-U/ml IgM: 0-80
MPL/U/ml / 1GPL-U/m |
10 ul serum or plasma |
quantitative |
MTPL |
96 wells |
103,000 |
| Cardiolipin
IgM (ref. sera optional, price on req.) |
EIA2789 |
20, 20, 10 RT |
|
serum, 10uL |
semi-quant. |
MTPL |
96 wells |
80,000 |
| Cardiolipin
Screen IgG/IgM anti- Elisa |
EIA3589 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| Caspase-8
(human) Elisa |
EIA4863 |
2 hs / 1 hr / 20 min. at RT |
0.16 - 10 ng/mL /// 0.10 ng/mL |
50 ul cell lysate, cell culture
supernatants, s |
quantitative |
MTPL |
96 wells |
223,000 |
| Caspase-9
(human) Elisa |
EIA4860 |
2 hrs / 1 hr/ 20 min. at RT |
1.6 - 100 ng/mL /// 0.4 ng/mL |
50 ul cell lysate, cell culture
supernatants, s |
quantitative |
MTPL |
96 wells |
223,000 |
| Cathepsin
G, anti- Elisa |
EIA3600 |
|
|
|
quantitative |
MTPL |
96 wells |
116,000 |
| CAV
(Canine Adeno Virus) antibodies |
EIA2480 |
60/60/20 min |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
VET. |
96 wells |
160,000 |
| CCP2
(anti-CCP2) Elisa (1 control
incl.) |
EIA5134 |
60 / 30 / 15 min |
1 - 2000 U/ml /// 1.2 U/ml |
10 ul serum/plasma (diluted
1:100) |
quantitative |
MTPL |
96 wells |
209,000 |
| CCV
(Canine Corona Virus) IgG antibodies |
EIA2482 |
60/60/20 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
VET. |
96 wells |
160,000 |
| CCV
(Canine Corona Virus) IgM antibodies |
EIA2483 |
60/60/20 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
VET. |
96 wells |
183,000 |
| CD23
(soluble) Elisa |
EIA3874 |
2h/30min |
1 - 20 U/mL 0.15U/mL |
50 ul serum |
quantitative |
MTPL |
96 wells |
352,000 |
| CDV
(Canine Distemper Virus) IgG antibodies |
EIA2478 |
60/60/15 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:50 - 1:1350) |
|
VET. |
96 wells |
160,000 |
| CDV
(Canine Distemper Virus) IgM antibodies |
EIA2479 |
60/60/15 min. |
Negative and Positive Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
VET. |
96 wells |
183,000 |
| CEA |
EIA1868 |
60 / 15 min. |
0 - 100 ng/ml // 0.44 ng/ml |
50 ul serum / plasma |
quantitative |
MTPL |
96 wells |
65,000 |
| CEA |
EIA1871 |
80 min. at RT |
1.0 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
65,000 |
| Centromer
B, anti- Elisa |
EIA3569 |
|
|
|
quantitative |
MTPL |
96 wells |
105,000 |
| CETP
Activity (Cholesteryl ester
transfer protein) |
EIA4414 |
30 - 60 min 37 C |
zero standards |
1-3 ul serum / plasma |
qualitativ |
Activ. A. |
100 tests |
371,000 |
| CH 50 |
EIA3989 |
120/15 min |
controls qualitative |
50 ul serum |
qualitative |
MTPL |
96 wells |
95,000 |
| Chemerin
human Elisa |
EIA5065 |
60 / 60 / 30 / 15 min |
0.5 - 16 ng/mL /// 0.13 ng/mL |
100 uL serum and plasma |
quantitative |
MTPL |
96 wells |
411,000 |
| Chikungunya
IgG |
EIA5102 |
60/30/30/30/15 min |
neg., pos., cut-off control
/// >90% |
10 uL serum or plasma |
qualitative |
MTPL |
96 wells |
183,000 |
| Chikungunya
IgM Elisa |
EIA5103 |
60/30/30/15 min. |
neg., pos., cut-off control /// >90% |
10 uL serum or plasma |
qualitative |
MTPL |
96 wells |
183,000 |
| Chlamydia IgM (pneumoniae) |
EIA2941 |
|
|
|
qualitative |
MTPL |
96 wells |
200,000 |
| Chlamydia
(psittaci/trachomatis) Ab (cats only) |
EIA2474 |
50/60/10 min. |
Positive and Negative Control |
100 ul Serum (1:50 diluted) |
|
VET. |
96 wells |
170,000 |
| Chlamydia
IgA (pneumoniae) |
EIA2942 |
|
|
|
qualitative |
MTPL |
96 wells |
200,000 |
| Chlamydia
IgA (trachomatis) |
EIA3461 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Chlamydia
IgG (pneumoniae) |
EIA2940 |
|
|
|
qualitative |
MTPL |
96 wells |
200,000 |
| Chlamydia
IgG (pneumoniae) |
EIA3912 |
1 h 37 C / 30', 15' RT |
pos. + neg. control |
10 ul serum or plasma |
qualitative |
MTPL |
96 wells |
103,000 |
| Chlamydia
IgG (trachomatis) |
EIA3462 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Chlamydia
IgM (pneumoniae) |
EIA3913 |
1 h 37 C / 30', 15' RT |
pos. + neg. control |
10 ul serum or plasma |
qualitative |
MTPL |
96 wells |
103,000 |
| Chlamydia
IgM (trachomatis) |
EIA3463 |
60 min. 37C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Cholecystokinin
(CCK) (26-33) (nonsulfated) (human, rat, mouse) Elisa |
EIA4393 |
2h / 1h/ 1h RT |
0 - 100 ng / ml /// - |
50 ul plasma |
quantitative |
MTPL |
96 wells |
177,000 |
| Chromogranin
A Elisa 2nd generation |
EIA4521 |
60/ 60 / 20 min |
19.2 - 660 NG/ML /// 2 NG/ML |
15 ul serum |
quantitative |
MTPL |
96 wells |
158,000 |
| CHV
(Canine Herpes Virus) antibodies |
EIA2481 |
60/60/20 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
VET. |
96 wells |
160,000 |
| CK-MB |
EIA4112 |
|
|
|
quantitative |
MTPL |
96 wells |
75,000 |
| Clostridium
piliforme (mouse) EcoElisa |
EIA4952 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil .serum |
qualitative |
VET |
48 wells |
232,000 |
| Clostridium
piliforme (mouse) EcoElisa |
EIA4953 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Clostridium
piliforme (rat) EcoElisa |
EIA4954 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Clostridium
piliforme (rat) EcoElisa |
EIA4955 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| CMV IgG |
EIA1797 |
90 min at RT |
|
serum |
quantitative |
MTPL |
96 wells |
65,000 |
| CMV IgG
(Cytomegalovirus) |
EIA3468 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| CMV IgG
(qualitative) |
EIA5153 |
60/30/15 min |
pos. and neg. control /// 98 % |
10 uL serum, plasma |
qualitative |
MTPL |
96 wells |
63,000 |
| CMV IgM |
EIA1796 |
90 min at RT |
|
serum |
quantitative |
MTPL |
96 wells |
67,000 |
| CMV IgM
(Cytomegalovirus) |
EIA3469 |
60 min 37C; 30 / 15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| CMV IgM
CLA |
CLA5196 |
30min 37C / 30 / 15 min. RT |
3 standards |
10 ul serum |
quantitative |
MTPL |
96 wells |
71,000 |
| Corona/
Sialodacryoadenitis Virus (rat) EcoElisa |
EIA4974 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Corona/
Sialodacryoadenitis Virus (rat) EcoElisa |
EIA4975 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Corticosterone
(rat) Elisa |
EIA5186 |
120 / 30 min |
15 - 2250 ng/ml /// 4.5 ng/ml |
10 ul serum / plasma |
quantitative |
MTPL |
96 wells |
177,000 |
| Corticosterone
Elisa |
EIA4164 |
60 / 15 min. |
0 - 240 nmol/l // Sensitivity to determine |
20 ul serum / plasma |
quantitative |
MTPL |
96 wells |
97,000 |
| Corticotropin
Releasing Factor (CRF) mouse, rat, human Fluorescent Elisa |
EIA5082 |
16 - 24 hours at 4 C, 1.5 / 1 h
/ 15 - 20 min at RT |
1-10000 pg/ml /// / |
50 ul prepared blood sample |
quantitative |
MTPL |
96 wells |
198,000 |
| Corticotropin
Releasing Factor (human - rat - mouse) |
EIA1631 |
4 hrs. at RT |
0.2-2.0 ng/ml |
plasma |
quantitative |
MTPL |
96 wells |
177,000 |
| Cortisol |
CLA4651 |
30 / 10 - 15 min |
0.5 - 60 ug/dL /// 0.15 ug/dl |
20 ul serum |
quantitative |
MTPL |
96 wells |
80,000 |
| Cortisol
(human) |
EIA1887 |
1 hour @ RT |
2,5 ng/ml |
serum / plasma |
quantitative |
MTPL |
96 wells |
61,000 |
| Cortisol
(human) salivary |
SLV2930 |
60 / 30 min |
2000 - 80000 pg/ml // 1140 pg/ml |
100 ul saliva |
quantitative |
MTPL |
96 wells |
73,000 |
| Cortisol
(serum) CLA |
CLA4666 |
30 / 10 min |
20-800 ng/ml /// 0.48 ng/ml |
20 ul serum |
quantitative |
MTPL |
96 wells |
65,000 |
| Cortisol
(urinary) EIA |
EIA2989 |
|
|
|
quantitative |
MTPL |
96 wells |
88,000 |
| Cortisol
HS salivary |
SLV4635 |
60/30 min |
0.1 - 30 ng/ml /// 0.03 ng/ml |
100 ul saliva |
quantitative |
MTPL |
96 wells |
73,000 |
| Cortistatin-14
(rat) |
EIA3802 |
|
|
|
quantitative |
MTPL |
96 wells |
177,000 |
| Cotinine
(saliva) EIA |
EIA3243 |
30/30 min. |
5 - 50 ng/ml Cotinine (3
calibrators) |
Saliva samples |
semi-quant. (3calibr |
MTPL |
96 wells |
154,000 |
| Cotinine
(serum) EIA |
EIA3242 |
30/30 min. |
10 - 50 ng/ml |
serum or plasma samples |
semi-quant. (3calibr |
MTPL |
96 wells |
154,000 |
| Cotinine
(urine) EIA |
EIA1377 |
30/30 min. at RT |
neg/pos control |
urine |
qualitative |
MTPL |
96 wells |
154,000 |
| Coxiella
burnetti (Q-Fever) Phase 1 IgG |
EIA5188 |
60 / 30 / 15 min. |
--- /// 88% |
10 uL serum |
qualitative |
MTPL |
96 wells |
132,000 |
| Coxiella
burnetti (Q-Fever) Phase 2 IgG |
EIA5189 |
60 / 30 / 16 min. |
--- /// >90 % |
10 uL serum |
qualitative |
MTPL |
96 wells |
132,000 |
| Coxiella
burnetti (Q-Fever) Phase 2 IgM |
EIA5187 |
60 / 30 / 15 min |
--- /// >90 % |
10 uL serum |
qualitative |
MTPL |
96 wells |
132,000 |
| Coxsackie
B Virus IgM (min. order 10 kits) |
EIA5175 |
60 / 60, 37 C / 20 min RT |
pos. + neg. control. /// >98% |
10 ul serum, plasna |
qualitative |
MTPL |
96 wells |
97,000 |
| C-Peptide |
EIA1293 |
270 min. at RT |
0.2-16 ng/ml |
serum, plasma, urine |
quantitative |
MTPL |
96 wells |
65,000 |
| C-Peptide
(human) |
EIA4262 |
60 / 60 / 15 min. |
95 - 3720 pmol/l // 15 pmol/l |
25 ul serum, plasma or urine
(dilute urine samp |
quantitative |
MTPL |
96 wells |
200,000 |
| CPV
(canine parvo virus) antigen Faeces |
EIA2477 |
50/50/15 min. |
Positive and Negative Control |
100 ul Serum (1:2 diluted) |
|
VET. |
96 wells |
194,000 |
| CPV IgG
(canine parvo virus) antibodies Faeces |
EIA2475 |
60/60/60/15 min |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:50 - 1:1350) |
|
VET. |
96 wells |
154,000 |
| CPV IgM
(canine parvo virus) antibodies |
EIA2476 |
60/60/60/15 min |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:50 - 1:1350) |
|
VET. |
96 wells |
166,000 |
| Cripto-1
Elisa |
EIA5109 |
180 / 30 / 20 min. |
50 - 800 pg/ml /// 8.4 pg/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
177,000 |
| CRP
(canine) Elisa |
EIA4694 |
30 / 30 / 10 min |
1.5 - 40 ug/mL /// 3.6 ng/ml |
2 ul serum |
quantitative |
VET. |
96 welss |
upon req. |
| CRP
(C-Reactive Protein) |
EIA1952 |
30/10/30 min. |
0-100 ug/ml 1ug/ml |
human serum and plasma |
quantitative |
MTPL |
96 wells |
99,000 |
| CRP
(mouse) Elisa |
EIA4823 |
60/30/5-10min |
1.56 - 25 ng/ml /// 2.5 ng/ml |
10 ul serum / plasma / fluids |
quantitative |
VET. |
96 wells |
177,000 |
| CRP
(Porcine) Elisa |
EIA5192 |
30 / 30 / 10 min |
6.25-200 ng/ml /// / |
5 ul pig biological samples |
quantitative |
MTPL |
96 wells |
211,000 |
| CRP
(rat) Elisa |
EIA4695 |
30 / 30 5 - 10 min |
4.9 - 133.3 ul/mL /// 2.5 ug/ml |
2 ul serum |
quantitative |
VET. |
96 wells |
177,000 |
| CRP
Elisa (hs CRP) |
EIA4584 |
30 / 30 / 10 min |
0.4 - 10 ug/ml // 0.02 g/ml |
10 ul serum, plasma |
quantitative |
MTPL |
96 wells |
99,000 |
| CRP, HS
(C-Reactive Protein) |
EIA3954 |
|
|
|
quantitative |
MTPL |
96 wells |
69,000 |
| Cryptosporidium
Ag (stool) |
EIA3467 |
30 / 5 / 5 / 5 min. |
pos. / neg. control // 93 % |
stool |
qualitative |
MTPL |
96 wells |
82,000 |
| CTGF
(connective tissue growth factor) |
EIA5195 |
120/60/30/15 min |
1 - 500 ng/ml /// 3.24 ng/ml |
25 ul serum |
quantitative |
MTPL |
96 wells |
upon req. |
| Cyclic
AMP |
EIA2096 |
|
|
|
quantitative |
MTPL |
192 wells |
175,000 |
| Cyclic
AMP direct (one plate) |
EIA5204 |
120 / 30 min |
0.617-150 pmol/mL /// 0.64 pmol/mL |
50 ul saliva, urine, serum, EDTA
& heparin plas |
quantitative |
MTPL |
96 wells |
124,000 |
| Cyclic
GMP |
EIA2097 |
|
|
|
quantitative |
MTPL |
192 wells |
175,000 |
| Cyfra
21-1 |
CLA4731 |
30 min. |
3 - 50 ng/ml /// 0.03 ng/ml |
50 ul serum, heparin plasma |
qualitative |
MTPL |
96 wells |
132,000 |
| Cyr 61
Elisa (CCN1) |
EIA5108 |
120 / 30 / 15 min |
40 - 1000 pg/ml /// 19.4 pg/ml |
50 ul serum, plasma (EDTA,
Heparin), urine |
quantitative |
MTPL |
96 wells |
179,000 |
| Cystatin
C (human) Elisa |
EIA4394 |
30 / 30 / 5-10 min |
1 - 5000 ng/ml // 0.02 ng/well |
10 ul serum and tissue culture
medium |
quantitative |
MTPL |
96 wells |
204,000 |
| Cysticercosis |
EIA2905 |
|
|
|
quantitative |
MTPL |
96 wells |
88,000 |
| Cytomegalovirus
(guinea pig) EcoElisa |
EIA4958 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Cytomegalovirus
(guinea pig) EcoElisa |
EIA4959 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Cytomegalovirus
(mouse) EcoElisa |
EIA4956 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Cytomegalovirus
(mouse) EcoElisa |
EIA4957 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| D |
|
|
|
| Dengue
IgG |
EIA3470 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Dengue
IgM |
EIA3471 |
60 min 37 C; 30 / 15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| DHEA
(Dehydro-epiandrosterone) Elisa |
EIA3415 |
60/15 min. |
0-30 ng/ml |
20 ul serum |
quantitative |
MTPL |
96 wells |
69,000 |
| DHEA S
(Dehydro-epiandrosterone Sulphate) |
EIA1562 |
75 min. at RT |
0.1-10 ug/ml |
serum, plasma |
quantitative |
MTPL |
96 wells |
61,000 |
| DHEA
Salivary Elisa |
SLV3012 |
60/20 min |
10 - 1440 pg/mL /// 3.3 pg/ml |
50 ul saliva |
quantitative |
MTPL |
96 wells |
73,000 |
| DHEA-S |
CLA4652 |
30 / 10 - 15 min |
0.02 - 10 ug/dL /// 0.02 ug/dl |
25 ul serum |
quantitative |
MTPL |
96 wells |
82,000 |
| DHEA-S
(serum) CLA |
CLA4667 |
min. |
|
serum |
quantitative |
MTPL |
96 wells |
65,000 |
| DHEA-S
Saliva |
SLV4409 |
15 min. 37C / 15 min. RT |
0.2 - 12 ng/ml // 25 pg/mL |
50 uL Saliva |
quantitative |
MTPL |
96 wells |
88,000 |
| Diabetes
Control Set (human Insulin) Low + High (unit 2 x 0.5 ml) |
CTL5132 |
|
|
|
controls |
|
2 x 0.5ml |
67,000 |
| Diabetes-antigen
Control (rat, mouse) (3 vials /ea.0.5ml)<low,medium, high> |
CTL4783 |
|
|
|
controls |
|
3 vials /0.5 ml ea. |
78,000 |
| Digoxin |
EIA3268 |
|
|
|
quantitative |
MTPL |
96 wells |
63,000 |
| Diol, 3
alpha diol G (5aAndrostone 3a17Bdiol Glucuronide) |
CLA4649 |
15 /15 min |
0.25 - 50 ng/ml // 0.1 ng/ml |
5 ul serum |
quantitative |
MTPL |
96 wells |
82,000 |
| Diphtheria
IgG Toxoid Ab (corynebacterium diphtheriae) |
EIA3466 |
10 / 5 / 5 min |
4 standards (conc:?) // - |
100 ul serum (diluted 1:100 and
a 1:1,000 dilut |
quantitative |
MTPL |
96 wells |
82,000 |
| DNA (ds)
anti- Antibody* |
EIA2574 |
|
Positive, negative Control,
positive calibrator |
|
|
|
96 wells |
181,000 |
| DNA (ds)
IgA, anti- Elisa |
EIA3565 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| DNA (ds)
IgG |
EIA2774 |
20, 20, 10 RT. |
|
10 uL serum |
semi-quant. |
MTPL |
96 wells |
82,000 |
| DNA
(ds) IgM, anti Elisa |
EIA3564 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| DNA
(ds) Screen, anti- Elisa |
EIA3566 |
30 / 15 / 15 min |
12.5 - 200 U/ml // 1U/ml |
10 ul serum / plasma |
quantitative |
MTPL |
96 wells |
92,000 |
| DNA (ss)
anti- Elisa |
EIA3567 |
|
|
|
|
|
96 wells |
103,000 |
| Dopamin
Research Elisa |
EIA4824 |
30 / 120 / 30 / 30 min |
25 - 6,400 pg/sample /// 8.3 pg/sample |
1-100 uL tissues homogenates,
dialysates and ot |
quantitative |
MTPL |
96 wells |
228,000 |
| Dopamine
Elisa |
EIA4161 |
30 min 37 C, 120, 30, 40-45 min
RT |
0 - 3840 ng/ml // 7.5 ng/ml
urin, 12.5 pg/ml plasm |
600 ul plasma o. 10 ul urine |
quantitative |
MTPL |
96 wells |
204,000 |
| Dopamine
Elisa |
EIA4615 |
120/60/40 min |
12-2250 ng/mL // urin 5 ng/mL; plasma 4 pg/ml |
500 uL plasma, 20 uL urine |
quantitative |
MTPL |
96 wells |
190,000 |
| Drugs of
Abuse Control elevated immunoassay, level 4 |
CTL5079 |
|
|
|
controls |
|
6x18mL |
170,000 |
| Drugs of
Abuse Control High challenge to immunoassay cutoff, level 3 |
CTL5078 |
|
|
|
controls |
|
6x18mL |
170,000 |
| Drugs of
Abuse Control low challenge to immunoassay cutoff, Level 2 |
CTL5077 |
|
|
|
controls |
|
6x18mL |
170,000 |
| Drugs of
Abuse Control negative, Level 1 (6 x 18 mL) |
CTL5076 |
|
|
|
controls |
|
6x18mL |
113,000 |
| E |
|
|
|
| E. Coli
Verotoxin 1+2 Ag (stool) Elisa |
EIA4452 |
60/30/30/15 min |
pos./neg. control // 84.6 % |
stool speciment |
qualitative |
MTPL |
96 wells |
116,000 |
| Echinococcus
granulosus IgG |
EIA3472 |
10 / 5 / 5 min. |
pos./ neg. / cut off control
/ 97.8 % |
100 ul serum (diluted 1:64) |
qualitative |
MTPL |
96 wells |
76,000 |
| Ectromelia
Virus (mouse) EcoElisa |
EIA4960 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil serum |
qualitative |
VET |
48 wells |
232,000 |
| Ectromelia
Virus (mouse) EcoElisa |
EIA4961 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| EGF
(human) (Epidermal Growth Factor) |
EIA1734 |
3 hrs. at RT |
0.5 ng/ml |
Urine |
quantitative |
MTPL |
96 wells |
190,000 |
| ENA
Combi |
EIA3572 |
|
|
|
quantitative |
MTPL |
96 wells |
99,000 |
| ENA
Screen (entractable nuclear antigen) |
EIA2779 |
20, 20, 10 RT |
|
serum, 10 uL |
semi-quant. |
MTPL |
96 wells |
92,000 |
| ENA-4-Profile
Elisa |
EIA3977 |
30'/15'/15'/15'/5' |
qualitative, cut-off OD Quotient |
10 ul serum or plasma |
qualitative |
MTPL |
4x24 tests |
111,000 |
| ENA-6-Profile |
EIA2780 |
20, 20, 10 RT |
|
serum, 50 uL |
semi-quant. |
MTPL |
96 wells |
78,000 |
| ENA-6-Profile |
EIA3901 |
30' RT |
Qualt., Cut-off OD-Quotient |
10 ul Serum or Plasma |
qualitative |
tests |
6x16 tests |
111,000 |
| ENA-6-Screen |
EIA3571 |
|
|
|
quantitative |
MTPL |
96 wells |
99,000 |
| Encephalitozoon
cuniculi (guinea pig) EcoElisa |
EIA4966 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Encephalitozoon
cuniculi (guinea pig) EcoElisa |
EIA4967 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Encephalitozoon
cuniculi (hamster EcoElisa |
EIA4969 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Encephalitozoon
cuniculi (hamster) EcoElisa |
EIA4968 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Encephalitozoon
cuniculi (mouse) EcoElisa |
EIA4962 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Encephalitozoon
cuniculi (mouse) EcoElisa |
EIA4963 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Encephalitozoon
cuniculi (rat) EcoElisa |
EIA4964 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Encephalitozoon
cuniculi (rat) EcoElisa |
EIA4965 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Endothelin
2 (ET-2) (human - canine) |
EIA3421 |
|
|
|
quantitative |
MTPL |
96 wells |
177,000 |
| Endothelin-1
(H - R - M - B - P - C - R) |
EIA3420 |
|
|
|
quantitative |
MTPL |
96 wells |
177,000 |
| Entamoeba
histolytica IgG (Amebiasis) Elisa |
EIA3474 |
10 / 5 / 5 min. |
pos. / neg. control // 92 % |
100 ul serum (diluted 1:64) |
qualitative |
MTPL |
96 wells |
82,000 |
| Epstein
Barr Virus (EBV-EBNA) IgG |
EIA4246 |
60 37 C; 30 / 15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Epstein
Barr Virus (EBV-EBNA) IgM |
EIA4247 |
60 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Epstein
Barr Virus (EBV-VCA) IgG |
EIA3475 |
60 37 C; 30 / 15 min RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Epstein
Barr Virus (EBV-VCA) IgM |
EIA3476 |
60 37C; 30 / 15 min RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| Epstein
Barr Virus EA IgG |
EIA2796 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
MTPL |
96 wells |
73,000 |
| Epstein
Barr Virus EA IgM, Elisa |
EIA2518 |
60 / 30 / 20 min |
1 - 200 U/mL /// >95% |
|
qualitative |
MTPL |
96 wells |
118,000 |
| Epstein
Barr Virus EBNA IgA*, Elisa |
EIA2519 |
|
|
|
|
|
96 wells |
128,000 |
| Epstein
Barr Virus EBNA-1 IgG |
EIA2795 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
MTPL |
96 wells |
73,000 |
| Epstein
Barr Virus VCA IgG |
EIA2793 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
MTPL |
96 wells |
73,000 |
| Epstein
Barr Virus VCA IgM |
EIA2794 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
MTPL |
96 wells |
88,000 |
| Erythropoietin
(Epo) - single-step sandwich assay - |
EIA3646 |
16 - 20 hrs |
6mU/mL |
human serum |
quantitative |
MTPL |
96 wells |
109,000 |
| Estradiol |
EIA2693 |
2 hrs at RT |
25-2000 pg/mL /// 9.714 pg/mL |
serum, plasma |
quantitative |
MTPL |
96 wells |
61,000 |
| Estradiol
(serum) CLA |
CLA4664 |
min |
|
serum |
quantitative |
MTPL |
96 wells |
69,000 |
| Estradiol
Saliva (E2) |
SLV4188 |
120/30 min. |
0.1 - 100 pg/ml // 0.085 pg/ml |
100ul saliva |
quantitative |
MTPL |
96 wells |
73,000 |
| Estradiol
US (ultra sensitive) |
EIA4399 |
4 h / 30 min. |
3 - 200 pg/ml // < 1pg/ml |
100 ul serum, plasma |
quantitative |
MTPL |
96 wells |
86,000 |
| Estriol
(E3), Free |
EIA1612 |
90 min. at RT |
1-40 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
65,000 |
| Estriol
Saliva |
CLA4653 |
45 / 20 / 10 - 15 min |
0.1 - 100 pg/ml /// 0.7 pg/ml |
50 ul saliva |
quantitative |
MTPL |
96 wells |
82,000 |
| Estriol,
Free (saliva) |
SLV3653 |
60 min. 37 C / 15 min RT |
0.1 - 12 ng/ml // 2 pg/ml |
20 ul Saliva |
quantitative |
MTPL |
96 wells |
88,000 |
| Estriol,
total |
EIA3717 |
1 h 15 min. |
2,0 - 200,0 ng/ml /
40 pg |
20 ul |
quantitative |
MTPL |
96 wells |
80,000 |
| Estrone |
EIA4079 |
1 hr. |
|
|
|
|
96 wells |
76,000 |
| Estrone
Elisa |
EIA4174 |
60/30 min. |
15 - 2000 pg/ml // 6,3 pg/ml in research |
50 ul Serumin research |
quantitative |
MTPL |
96 wells |
76,000 |
| Estrone
Saliva |
CLA4655 |
60 / 30 / 10 - 15 min |
2 - 800 pg/ml // 1.0 pg/ml |
100 ul saliva |
quantitative |
MTPL |
96 wells |
84,000 |
| Estrone
Serum |
CLA4654 |
30 / 10 - 15 min |
15 - 2000 pg/ml /// 8.8 pg/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
82,000 |
| F |
|
|
|
| Fasciola
hepatica (bovine, sheep) Elisa |
EIA5075 |
2hrs 10min |
pos. control /// n.d. |
10 uL serum, 25 uL milk |
|
|
96 wells |
145,000 |
| Fasciola
Hepatica IgG (human) Elisa |
EIA4503 |
60 37 C; 30 / 15 min RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
97,000 |
| FCoV Ab
(indication for FIP disease) |
EIA2468 |
60/60/20 min |
Positive and Negative Control |
100 ul Serum ( 3-fold diluted,
1:30 - 1:810) |
|
VET. |
96 wells |
190,000 |
| FCV
(Feline Calici Virus) antibodies |
EIA2473 |
60/60/60/15 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1-810) |
|
VET. |
96 wells |
170,000 |
| FeLV-gp70
(Feline Leukemia Virus-GP70) antibodies, virus coated |
EIA2470 |
90/60/75/15 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
VET. |
96 wells |
177,000 |
| FeLV-p27
(Feline Leukemia Virus) antigen |
EIA2469 |
20/20/15 min |
Positive and Negative Control |
50 ul Serum (dilution 1:1) |
|
VET. |
96 wells |
156,000 |
| Ferritin |
EIA1872 |
80 min. at RT |
5.0 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
67,000 |
| Ferritin
Elisa |
EIA4292 |
30 / 15 / 15 min. |
15 - 1500 ng/ml // 5ng/ml |
25 ul serum, plasma |
quantitative |
MTPL |
96 wells |
94,000 |
| Ferritin
Elisa |
EIA4408 |
60 / 10 min |
5 - 100 ng/ml // 1.0 ng/ml |
20 uL serum / plasma |
quantitative |
MTPL |
96 wells |
67,000 |
| Fetuin
A Elisa |
EIA4522 |
120/ 30 / 20 min |
12.5 - 370 ng/ml // 5 ng/ml |
25 ul diluted serum, Tissues
extracts |
quantitative |
MTPL |
96 wells |
158,000 |
| FGF-19
Elisa (human) |
EIA5156 |
60/60/30/10 min |
12.5 - 800 ng/ml /// 4.8 pg/ml |
50 ul serum and plasma |
quantitative |
MTPL |
96 wells |
274,000 |
| FHV
(Feline Herpes Virus) antibodies |
EIA2472 |
60/60/15 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
VET. |
96 wells |
162,000 |
| Fibronectin,
(human) |
EIA1736 |
3 hrs. at 37 C. |
|
Biological sample |
quantitative |
MTPL |
96 wells |
198,000 |
| FIV
p24/p17 (Feline Immunodeficiency Virus) Ab |
EIA2463 |
45/50/10 min |
Positive and Negative Control |
100 ul serum (1:100 diluted) |
|
VET. |
96 wells |
162,000 |
| Fodrin,
anti-alpha-Fodrin |
EIA3978 |
|
|
|
|
MTPL |
96 wells |
126,000 |
| Food
Additives Allergy Screening Elisa |
EIA4725 |
60 / 30 / 10 min |
50 - 400 U/ml /// - |
25 uL serum |
quantitative |
MTPL |
288 wells |
149,000 |
| Food
Allergies IgG - Allerquant 90G |
EIA1745 |
overnight at 2-8 C |
on request |
serum |
quantitative |
MTPL |
288 tests |
114,000 |
| FPV
(Feline Panleucopenia Virus = Felepine Parvo Virus) Ab EIA |
EIA2467 |
60/60/60/10 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:50 - 1:1350) |
|
VET. |
96 wells |
170,000 |
| FPV
(Feline Panleukopenia Virus = Feline Parvo Virus) ag EIA |
EIA2466 |
50/60/15 min. at 37 C |
Positive and Negative Control |
100 ul Faeces (1:2 diluted) |
qualitative |
VET. |
96 wells |
162,000 |
| FSH
(Follicle Stimulating Hormone) |
EIA1288 |
40 min. at RT |
5-100 mIU/ml |
serum |
quantitative |
MTPL |
96 wells |
57,000 |
| FSH
(Follicle Stimulating Hormone) |
EIA1785 |
1 hr. at RT |
2.5 mIU/ml |
serum |
quantitative |
MTPL |
96 wells |
59,000 |
| FSH
Elisa |
EIA5219 |
15 / 30 / 10 min |
5-135 mlU/ml /// 1.0 mlU/ml |
25 ul serum and plasma |
quantitative\ |
MTPL |
96 wells |
59,000 |
| G |
|
|
|
| GAD-65,
anti EIA |
EIA1910 |
150 min RT |
- /// 85 % |
serum |
qualitative |
MTPL |
96 wells |
154,000 |
| Galactose
(with Membrane Plate) |
EIA1488 |
90 min. at RT |
<1.5 mg/dL |
blood |
quantitative |
MTPL |
960 wells |
upon req. |
| Galactose
(without Membrane Plate) |
EIA1489 |
90 min at RT |
<1.5 mg/dL |
blood |
quantitative |
MTPL |
960 wells |
upon req. |
| Galactose
neonatal (with Membrane Plate) |
EIA1486 |
90 min. at RT |
< 1.5 mg/dL |
blood |
quantitative |
MTPL |
192 wells |
111,000 |
| Galactose
neonatal (without Membrane Plate) |
EIA1487 |
90 min at RT |
<1.5 mg/dL |
blood |
quantitative |
MTPL |
192 wells |
94,000 |
| Galectin-3
(human) Elisa |
EIA4858 |
2 hrs / 1 hr/ 10 min. at RT |
0.39 - 25.0 ng/mL /// 0.12 ng/mL |
50 ul cell culture, serum,
plasma other biol. f |
quantitative |
MTPL |
96 wells |
223,000 |
| Gardenella
Vaginalis IgA Elisa |
EIA4516 |
60 / 60 / 15 min. |
- /
/ |
10 ul serum / vaginal liquid |
qualitative |
MTPL |
96 wells |
upon req. |
| Gardenella
Vaginalis IgG Elisa |
EIA4515 |
60 / 60 / 15 min |
- /
- |
10 ul serum / vaginal liquid |
quantitative |
MTPL |
96 wells |
upon req. |
| Gardnerella
Vaginalis IgM Elisa |
EIA4514 |
60 / 60 / 15 min |
- /
- |
10 ul serum / vaginal liquid |
qualitative |
MTPL |
96 wells |
upon req. |
| Gastrin
1 (human) EIA |
EIA3266 |
|
|
|
quantitative |
MTPL |
96 wells |
177,000 |
| Gastrin
Inhibitor Peptide (human) (GIP) |
EIA4142 |
2/1/1 hours |
0.41-3.12 ng/ml // 0.41 ng/ml |
50 ul plasma, serum, culture
media, tissue homo |
quantitative |
MTPL |
96 wells |
177,000 |
| Gastrin
Inhibitor Peptide (human) (GIP) Elisa |
EIA4527 |
90/60/30/20 min |
8.2 - 2000 pg/ml // 8.2 pg/ml |
20 ul serum, plasma, tissue
extract and cell cu |
quantitative |
MTPL |
96 wells |
215,000 |
| Gastrin
Inhibitor Peptide (rat/mouse) (GIP) Elisa |
EIA4528 |
90/60/30/18 min |
8.2 - 2000 pg/ml // 8.2 pg/ml |
10 ul serum, plasma, tissue
extract and cell cu |
quantitative |
MTPL |
96 wells |
215,000 |
| Gastro
Screen Blot (16 strips = unit) |
DOT5118 |
5 / 60 / 30 / 10 min |
on strip |
10 ul serum |
strip |
Immunoblot |
16 strips |
124,000 |
| Gastro
Screen Blot (8 strips = unit) |
DOT5117 |
5 / 60 / 30 / 10 min |
on strip |
10 ul serum |
strip |
Immunoblot |
8 strips |
90,000 |
| GBM,
anti- Elisa |
EIA3603 |
|
|
|
quantitative |
MTPL |
96 wells |
133,000 |
| Ghrelin
(active) human Elisa |
EIA4710 |
120/30/15 min. at RT |
25 - 2000 pg/mL /// 8 pg/mL |
20 ul serum or plasma |
quantitative |
MTPL |
96 wells |
225,000 |
| Ghrelin
(acylated) human Elisa |
EIA4686 |
3h / 30-60 min |
1.96 - 250 pg/ml /// 4 pg/ml |
100 uL (1:5 diluted) EDTA plasma
o. butter solu |
quantitative |
MTPL |
96 wells |
261,000 |
| Ghrelin
(human) |
EIA3706 |
|
|
|
quantitative |
MTPL |
96 wells |
177,000 |
| Ghrelin
(rat - mouse) |
EIA3707 |
|
|
|
quantitative |
MTPL |
96 wells |
177,000 |
| Ghrelin
(total) human Elisa |
EIA4709 |
120/30/25 min. at RT |
100 - 5000 pg/mL /// 30 pg/mL |
20 uL serum or plasma |
quantitative |
MTPL |
96 wells |
225,000 |
| Gliadin
IgA |
EIA3370 |
|
|
|
qualitative |
MTPL |
96 wells |
82,000 |
| Gliadin
IgA (anti- ) Elisa |
EIA5081 |
30 / 30 / 10 min |
4 - 160 U/mL /// 90.9 % |
100 ul serum, plasma |
quantitative |
MTPL |
96 wells |
92,000 |
| Gliadin
IgG |
EIA3371 |
|
|
|
qualitative |
MTPL |
96 wells |
80,000 |
| Gliadin
IgG (anti- ) Elisa |
EIA5080 |
30 / 30 / 10 min |
4.7 - 100 U/mL /// 86.4 % |
100 ul serum, plasma |
quantitative |
MTPL |
96 wells |
92,000 |
| Gliadin
IgG, anti- Elisa |
EIA3605 |
|
|
|
quantitative |
MTPL |
96 wells |
99,000 |
| Gliadin
Screen, (Anti-Gliadin) Elisa |
EIA4465 |
30 / 15 / 15 min |
6.3 - 100 U/ml // 1 U/ml |
10 ul serum / plasma |
quantitative |
MTPL |
96 wells |
99,000 |
| Glucagon
Like Peptide 1 (active) |
EIA3056 |
|
|
|
quantitative |
MTPL |
96 wells |
194,000 |
| Glucagon
Like Peptide 1 (GLP-1) (7-26) Amide (human - rat - mouse) |
EIA4141 |
|
|
|
quantitative |
MTPL |
96 wells |
177,000 |
| Glucagon
like peptide-1 (GLP-1) total Elisa
<for export only> |
EIA5095 |
20-24h@2-8C / 20 min |
2.1 - 54 pmol/L /// 1 pmol/L |
100 ul Plasma |
quantitative |
MTPL |
96 wells |
149,000 |
| Glucagon
like peptide-1 (GLP-s) active (7-36)
- for export only > |
EIA5096 |
20-24h@2-9C / 20 min |
1.82 - 54.58 pmol/L /// 0.3 pmol/L |
100 ul Plasma |
quantitative |
MTPL |
96 wells |
183,000 |
| Glycodelin
(PP14) Elisa |
EIA3779 |
|
|
|
quantitative |
MTPL |
96 wells |
234,000 |
| Glycoprotein
1 IgG/IgM, anti-beta2
Elisa |
EIA3590 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| Glykoprotein
1 IgA, anti beta 2 - |
EIA3884 |
60' RT |
0 - 100 U/ml, 0.5U/ml |
10 ul serum or plasma |
quantitative |
MTPL |
96 wells |
103,000 |
| Glykoprotein
1 Screen, anti beta 2 |
EIA3911 |
30' / 15' / 15' RT |
Neg., cut-off, Pos., Strong Pos
Ctrl. / 0.5 U/ml |
10 ul serum or plasma |
qualitative |
MTPL |
96 wells |
105,000 |
| GM-CSF
(human) Elisa |
EIA4859 |
3 hrs / 10 min |
8 - 500 pg/mL /// 2.9 pg/mL |
50 ul cell culture, seru,m
plasma, amniotic flu |
quantitative |
MTPL |
96 wells |
223,000 |
| Growth
Hormone (Rat/Mouse) Elisa |
EIA4614 |
90/60/30/20 min |
0.21 - 50 ng/ml // 0.07 ng/ml |
10 ul rat or mouse serum,
plasma, tissue extrac |
quantitative |
MTPL |
96 wells |
265,000 |
| Growth
Hormone Releasing Factor (human) EIA |
EIA3429 |
|
|
|
quantitative |
MTPL |
96 wells |
177,000 |
| H |
|
|
|
| H.
Pylori Ag (stool) Elisa (extract. kit for stool not incl.) (min. order 10
kits) |
EIA4354 |
120/20 min. at 37 C |
0.1 - 1.0 ul/ml att.: also as
cut-off meth. poss. |
~ 0.2 grams |
quantitative |
MTPL |
48 wells |
135,000 |
| H.
Pylori Ag Stool Extraction Kit (access. kit to EIA4354) (min. order 10 kits) |
EIA4355 |
|
|
|
|
|
50 tests |
73,000 |
| H.
Pylori IgA |
EIA3483 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
92,000 |
| H.
Pylori IgA (min order 10 kits) |
EIA3902 |
60'/60' 37C, 20' RT |
0 - 100 U arb./ml // >98% |
10 ul serum, plasma (human) |
quantitative |
MTPL |
96 wells |
84,000 |
| H.
Pylori IgA, anti- (qualitative) |
EIA4099 |
|
|
|
qualitative |
MTPL |
96 wells |
67,000 |
| H.
Pylori IgG |
EIA3484 |
60 min 37 C; 30 / 15 min. RT |
pos / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| H.
Pylori IgG (Gastritus & Peptic Ulcer) qualitative |
EIA1791 |
1.5 hrs. at RT |
98% |
serum |
qualitative |
MTPL |
96 wells |
65,000 |
| H.
Pylori IgG (Gastritus & peptic Ulcer) quantitative |
EIA3057 |
|
|
|
quantitative |
MTPL |
96 wells |
69,000 |
| H.
Pylori IgG Elisa (min order 10 kits) |
EIA4056 |
60'/60' 37C, 20' RT |
0-100 Uarb/ml >98% |
10 ul serum, plasma (human) |
qualitative |
MTPL |
96 wells |
88,000 |
| H.
Pylori IgG, anti- (Gastritus & Peptic Ulcer) qualitative |
EIA4100 |
|
|
|
qualitative |
MTPL |
96 wells |
67,000 |
| H.
Pylori IgM (min. order 10 kits) |
EIA4051 |
60'/60' 37C, 20' RT |
neg., pos. control / > 98% |
10 ul serum, plasma (human) |
qualitative |
MTPL |
96 wells |
90,000 |
| H.
Pylori IgM (qualitative) |
EIA2111 |
|
|
|
qualitative |
MTPL |
96 wells |
71,000 |
| H.
Pylori IgM, anti- (qualitative) |
EIA4101 |
|
|
|
qualitative |
MTPL |
96 wells |
67,000 |
| HAMA
Elisa (human anti-mouse Ab) Magiwel |
EIA4195 |
30/15 min |
25 - 1000 ng/ml / - |
25 ul diluted serum samples
(1:101) |
quantitative |
MTPL |
96 wells |
101,000 |
| Hantaan
Virus (rat) EcoElisa |
EIA4970 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Hantaan
Virus (rat) EcoElisa |
EIA4971 |
30 / 30 / 20 min. |
pos. neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| HAV
Ab
(min. order 10 kits) |
EIA4233 |
60/60 min. 37 C, 20 min. RT |
nev. / pos. control // 100 %] |
100 ul serum, plasma (human) |
qualitative |
MTPL |
96 wells |
82,000 |
| HAV IgM
(capture) Elisa (min. order 10
kits) |
EIA4432 |
60 / 60 min 37 C/20 min RT |
pos. / neg. control / 99% |
10 ul serum, plasma |
qualitative |
MTPL |
96 wells |
84,000 |
| HAV IgM
Elisa |
EIA5210 |
20 / 20 / 10 min 37 C |
neg. + pos. control /// no |
5 ul serum or plasma |
qualitative |
MTPL |
48 wells |
65,000 |
| HAV IgM,
anti- (Kit for IgM Antibody to
Hepatitis A Virus) (ELISA) |
EIA3889 |
|
|
|
qualitative |
MTPL |
96 wells |
59,000 |
| HBc Ab
screening Elisa (min order
10kits) |
EIA4086 |
60/60 at 37C, 20 min. RT |
neg., pos., control, qualitative |
50 ul serum, plasma |
qualitative |
MTPL |
96 wells |
82,000 |
| HBc IgM |
EIA5212 |
20 / 20 / 10 min 37 C |
neg. + pos. control /// no |
5 ul serum or plasma |
qualitative |
MTPL |
48 wells |
65,000 |
| HBc IgM
Elisa (min. order 10kits) |
EIA4085 |
60/60 at 37C, 20 min. RT |
0-100 PEI U/ml /
100 % |
10 ul serum, plasma |
quantitative |
MTPL |
96 wells |
94,000 |
| HBc IgM,
anti- (Kit for IgM Antibody to
Hepatitis B Core Antigen) (ELISA) |
EIA3895 |
|
|
|
qualitative |
MTPL |
96 wells |
57,000 |
| HBc,
anti- (Kit for IgG/IgM Antibodies to Hepatitis B Core
Antigen) (ELISA) |
EIA3894 |
|
|
|
qualitative |
MTPL |
96 wells |
57,000 |
| HBcAb
Elisa |
EIA5211 |
30 / 15 min 37 C |
neg. + pos. control /// no |
50 ul serum or plasma |
qualitative |
MTPL |
96 wells |
65,000 |
| HBe,
anti- (Kit for Antibody to
Hepatitis B e Antigen) (ELISA) |
EIA3891 |
|
|
|
qualitative |
MTPL |
96 wells |
57,000 |
| HBeAb
Elisa |
EIA5213 |
30 / 15 min 37 C |
neg. + pos. control /// no |
50 ul serum or plasma |
qualitative |
MTPL |
96 wells |
65,000 |
| HBeAg (Kit for Hepatitis B e Antigen)
(ELISA) |
EIA3890 |
|
|
|
qualitative |
MTPL |
96 wells |
57,000 |
| HBeAg
Elisa |
EIA5214 |
30 / 15 min 37 C |
neg. + pos. control /// no |
50 ul serum or plasma |
qualitative |
MTPL |
96 wells |
65,000 |
| HbeAg/Ab
Elisa (min. order 10
kits) |
EIA4162 |
60/60 at 37 C, 20 min RT |
neg., pos. control,
qualitative / 0.5 PEI U/ml |
50 ul serum |
qualitative |
MTPL |
96 wells |
94,000 |
| HBs Ab
Elisa (min. order 10 kits) |
EIA4135 |
60/60' 37C, 20' RT |
0-500 WHO mlU/ml // 5 WHO mlU/ml |
100 ul serum, plasma |
quantitative |
MTPL |
96 wells |
82,000 |
| HBs Ag
Confirmation Elisa
(min. order 10 kits) |
EIA5166 |
30 min RT |
/// 100 % |
150 uL serum, plasma |
qualitative |
MTPL |
40 tests |
86,000 |
| HBs,
anti- (Kit for Antibody to
Hepatitis B Surface Antigen) (ELISA) |
EIA3893 |
|
|
|
qualitative |
MTPL |
96 wells |
57,000 |
| HBsAb |
EIA5215 |
30 / 15 min 37C |
neg. + pos. control /// no |
50 ul serum or plasma |
qualitative |
MTPL |
96 wells |
65,000 |
| HBsAg (Kit for Hepatitis B Surface Antigen)
(ELISA) |
EIA3892 |
|
|
|
qualitative |
MTPL |
96 wells |
57,000 |
| HBsAg
(confirmatory) (min. 10 kits) |
EIA3949 |
2/h/1h/20 min |
controls /
0.1 ug/ml |
200 ul serum, plasma |
qualitative |
MTPL |
96 wells |
65,000 |
| HBsAg
Elisa |
EIA5216 |
60 / 15 min 37 C |
neg. + pos. control /// no |
50 ul srum or plasma |
qualitative |
MTPL |
96 wells |
65,000 |
| HBsAg
one step (4th generation) Elisa
(min. order 10 kits) |
EIA4134 |
120 / 30 min |
--- /// 100 % |
150 ul serum, plasma |
qualitative |
MTPL |
192 wells |
92,000 |
| HBsAg
one step (4th generation) Elisa (min. order 10 kits) |
EIA4545 |
120 / 30 min |
--- /// 100 % |
150 ul serum, plasma |
qualitative |
MTPL |
96 wells |
69,000 |
| HCG
(intact), human serum only (human chorionic Gonadotropin) |
EIA1469 |
40 min. at RT |
std. range 5 - 1000 mIU/ml |
serum |
quantitative |
MTPL |
96 wells |
57,000 |
| HCG
(total), beta (human serum) |
EIA1911 |
60/15 min. |
5-200 mlU/ml |
25 ul serum |
quantitative |
MTPL |
96 wells |
57,000 |
| HCG
(visual) Elisa |
EIA2113 |
|
|
|
qualitative |
MTPL |
96 wells |
56,000 |
| hCG beta
(beta-human Chorionic Gonadotropin) |
EIA4115 |
|
|
|
quantitative |
MTPL |
96 wells |
63,000 |
| hCG
beta, free Elisa |
EIA4718 |
30 / 30 / 20 min |
2.5-50 ng/ml /// 0.196 ng/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
69,000 |
| HCG
Elisa (serum) |
EIA1783 |
1 hr. at RT |
2.0 mIU/ml |
serum |
quantitative |
MTPL |
96 wells |
61,000 |
| HCV /
Elisa |
EIA5209 |
30 / 30 / 10 min 37 C |
neg. + pos. control /// no |
10 ul serum or plasma |
qualitative |
MTPL |
96 wells |
65,000 |
| HCV
AB (min order 10 kits) |
EIA3903 |
45'/45' 37C, 15' RT /
>98% |
neg. / pos. control, qualt. |
10 ul serum, plasma (human) |
qualitative |
MTPL |
192 wells |
111,000 |
| HCV AB
(min order 10 kits) |
EIA4543 |
45'/45' 37C, 15' RT / >98% |
neg. / pos. control, qualit. |
10 ul serum, plasma (human) |
qualitative |
MTPL |
96 wells |
78,000 |
| HCV Ab
confirmatory (min. order 10 kits) |
EIA3970 |
60' 37C / 20' RT |
neg. / pos. controls qualitative |
10 ul Serum, Plasma (human) |
qualitative |
MTPL |
96 wells |
130,000 |
| HCV Ag
(min 10 kits per order) |
EIA5165 |
45 / 45 37 C /
15 min RT |
/// 100 % |
10 uL serum, plasma |
qualitative |
MTPL |
480 wells |
190,000 |
| HCV
anti- (Kit for Antibody to
Hepatitis C Virus) (ELISA) 3rd generation |
EIA3896 |
|
|
|
qualitative |
MTPL |
96 wells |
57,000 |
| HCV IgM
Sandwich (min order 10 kits) |
EIA3908 |
60'/60' 37C, 20' RT |
neg. / pos. control, qual. /
>98 % |
10 ul serum, plasma (human) |
qualitative |
MTPL |
96 wells |
94,000 |
| HDV Ab
Elisa
(min. order 10 kits) |
EIA4269 |
90' 37C, 20' RT |
negative + positive control |
50 ul serum, plasma |
qualitative |
MTPL |
96 wells |
114,000 |
| HDV Ag
Elisa
(min. order 10 kits) |
EIA4268 |
120'/60 37 C, 20' RT |
negative + positiv control |
100 ul serum, plasma |
qualitative |
MTPL |
96 wells |
114,000 |
| HDV IgM
Elisa (min. order 10kits) |
EIA4120 |
60'/60' 37C, 20' RT |
qualitative, neg+ps.
control / >98% |
5 ul serum, plasma |
qualitative |
MTPL |
96 wells |
109,000 |
| Heartworm
Ag Canine Elisa |
EIA4795 |
|
neg. / pos. control |
serum and plasma |
qualitative |
VET. |
96 wells |
179,000 |
| HepAK
Dot |
DOT4274 |
30/30/10-12 min. RT (+30 min
drying) |
no qualitative evaluat. (compare
with pos Dot cont |
10 ul serum, plasma |
pos. dot control |
bot strips |
96 (24x4) tests |
135,000 |
| HepAK
plus Dot |
DOT4275 |
30/30/10-12 min. RT (+30 min.
drying) |
no qualit. evaluation (compare
w. pos. Dot control |
10 ul serum, plasma |
pos. dot control |
blot strip |
120 (24x5) tests |
147,000 |
| Hepatitis
Virus (mouse) EcoElisa |
EIA4972 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Hepatitis
Virus (mouse) EcoElisa |
EIA4973 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Hepcidin
25 c-terminal Elisa |
EIA4705 |
30/180/45/30 min |
3.85 - 140.0 ng/mL /// 0.9 ng/mL |
20 ul serum |
quantitative |
MTPL |
96 wells |
227,000 |
| Hepcidin
Prohormone Elisa |
EIA4644 |
120 / 60 / 30 min |
10 - 1000 ng/ml /// 3.95 ng/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
196,000 |
| HETE-15 |
EIA1411 |
overnight at 2-8 C |
1.24 pg/ml |
plasma |
quantitative |
MTPL |
96 wells |
170,000 |
| HEV Ab
Elisa (min. order 10 kits) |
EIA4416 |
45/45 min. 37C / 15 min. RT |
pos. / neg. control // - |
10 uL serum, plasma |
qualitative |
MTPL |
96 wells |
82,000 |
| HEV IgG
(Hepatitis E Virus IgG) (min. order 2 kits) |
EIA1813 |
75 min. 37 C. |
cutoff value |
serum or plasma |
qualitative |
MTPL |
96 wells |
139,000 |
| HEV IgG
Elisa (min. order 10 kits) |
EIA4145 |
60, 60 min 37 C, 20 min. RT |
qualit., neg.+pos. control /
> 98% |
10 ul serum or plasma |
qualitative |
MTPL |
96 wells |
86,000 |
| HEV IgM
Elisa (min order 10 kits) |
EIA4417 |
60/60 min. 37 C / 20 min. RT |
pos./neg. control // - |
10 uL serum, Plasma |
qualitative |
MTPL |
96 wells |
86,000 |
| HGH
(Human Growth Hormone) |
EIA1787 |
1 hr at RT |
0.5 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
59,000 |
| HIAA
(5-Hydroxy-3-Indole Acetic Acid) |
EIA1886 |
overnight at 2-8 C. |
0.2 mg/L |
urine |
quantitative |
MTPL |
96 wells |
190,000 |
| HIAA ,
5-HIAA (urine) |
EIA4482 |
60/60/20-30 min |
0.5 - 50 mg/l // 0.17 mg/l |
50 ul urine |
quantitative |
MTPL |
96 wells |
149,000 |
| Histamine
Cell Culture Research Elisa |
EIA4616 |
15/30/10/15 min |
0.5 - 50 ng/ml // 0.2 ng/ml |
10 ul cell cultue |
quantitative |
MTPL |
96 wells |
149,000 |
| Histamine
Elisa - |
EIA4005 |
|
|
serum, plasma, urine, cell
culture, liquor |
qualitative |
MTPL |
96 wells |
149,000 |
| Histamine
Food Elisa |
EIA4428 |
30 / 10 / 15 min |
0,5 - 50 ug/l // 0.15 ug/l |
100 uL of extracts of fish meal,
fresh fish, mi |
quantitative |
MTPL |
96 wells |
149,000 |
| Histamine
Intolerance (DAO active) Elisa |
EIA4599 |
overnight, 30/45/90/30 min 37 C/
15 min RT |
6 to 60 U / ml // 2.5 U/ml. |
250 ul plasma or serum |
quantitative |
MTPL |
96 wells |
316,000 |
| Histamine
Research Elisa |
EIA4890 |
60/30min, Acylation; 15-20h
2-8C/ 60/30 min RT |
0.3 - 30 ng/ml /// 0.2 ng/mL |
10ul EDTA- plasma from diff.
animal species (+ |
quantitative |
MTPL |
96 wells |
221,000 |
| Histone,
anti- Elisa |
EIA3568 |
|
|
|
quantitative |
MTPL |
96 wells |
99,000 |
| HIV
1&2 Ab&Ag (min.
order 10 kits) |
EIA5167 |
60 / 30 / 30 37 C /
30 min RT |
/// 100 % |
15 uL serum, plasma |
qualitative |
MTPL |
192 wells |
111,000 |
| HIV
1&2 Ab&Ag (screening) Elisa (w/o CE) (min. order 10 kits) |
EIA5180 |
60 / 30 / 30 / 30 min |
... /// 100 % |
150 uL plasma / serum |
qualitative |
MTPL |
96 wells |
78,000 |
| HIV 1+2
Ab |
EIA5217 |
60/ 30/ 10 min 37 C |
neg. + pos. control /// no |
100 ul serum or plasma |
qualitative |
MTPL |
96 wells |
65,000 |
| HIV 1+2
IgG/M |
EIA3491 |
30/15 min 37 C; 15 min. RT |
pos. / neg. control |
20 ul serum |
qualitative |
MTPL |
96 wells |
90,000 |
| HIV
1+2, anti- (Sandwich) (Kit for Ab to human Immunodeficiency Virus 1&2)
(ELISA) |
EIA3897 |
|
|
|
qualitative |
MTPL |
96 wells |
57,000 |
| HMGB1
Elisa (High Mobility Group Box1 Protein) |
EIA5159 |
20-24 h 37C / 120/30 min RT |
2.5-80 (or 0.313-10) ng/ml /// 1.0 (or 0.2 ng/ |
10 (50) ul serum/plasma |
quantitative |
MTPL |
96 wells |
513,000 |
| HNP 1-3
(human), Elisa (Neutrophil Defensins) |
EIA5139 |
60/60/60/20-30 min |
41-10000 pg/ml /// 41 pg/ml. |
100 ul plasma (heparin or EDTA)
and cell cultur |
quantitative |
MTPL |
2x96 wells |
462,000 |
| Homocysteine |
EIA2925 |
|
|
|
quantitative |
MTPL |
96 wells |
323,000 |
| Homocysteine
Controls |
EIA3329 |
|
|
|
|
|
3x1 vial |
124,000 |
| hPL
(Placental Lactogen, Human) |
EIA1283 |
40 min. at RT |
1.25-20 mg/ml |
serum |
quantitative |
MTPL |
96 wells |
61,000 |
| HPV
IgG, Elisa (min. 10 kits) |
EIA4907 |
60/60 min 37C / 20 min RT |
- /// - |
10 uL serum, plasma |
qualitative |
MTPL |
96 wells |
94,000 |
| HsP 70
(anti human Hsp 70) (heat shock protein) Elisa |
EIA4470 |
120 / 60 / 15 min. |
31.25 - 10,000 ng/mL // 6.79 ng/mL |
100 uL serum |
quantitative |
MTPL |
96 wells |
266,000 |
| HSV 1
IgA*, Elisa |
EIA2532 |
|
|
|
|
|
96 wells |
128,000 |
| HSV 1
IgG |
EIA1802 |
90 min at RT |
|
serum |
quantitative |
MTPL |
96 wells |
65,000 |
| HSV 1
IgG (Herpes Simplex Virus) |
EIA3485 |
60 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| HSV 1
IgG (Herpes Simplex Virus) (ref.sera opt., price on req.) |
EIA2799 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
MTPL |
96 wells |
71,000 |
| HSV 1
IgM |
EIA1803 |
90 min at RT |
|
serum |
quantitative |
MTPL |
96 wells |
67,000 |
| HSV 1
IgM (Herpes Simplex Virus) |
EIA3486 |
60 37 min. C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| HSV 1
IgM (Herpes Simplex Virus) (ref. sera opt., price on req.) |
EIA2800 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
MTPL |
96 wells |
73,000 |
| HSV 1
IgM CLA |
CLA5199 |
30min 37C/ 30/15 min. RT |
|
10 uL serum |
qualitative |
MTPL |
96 wells |
71,000 |
| HSV 1+2
IgG (Herpes Simplex Virus) |
EIA3489 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+1)) diluted) |
qualitative |
MTPL |
96 wells |
76,000 |
| HSV 1+2
IgM (Herpes Simplex Virus) |
EIA3490 |
60 min. 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
82,000 |
| HSV 1+2
IgM (Herpes Simplex Virus) (ref. sera opt., price on req.) |
EIA2803 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
MTPL |
96 wells |
92,000 |
| HSV 2
IgG |
EIA1795 |
90 min at RT |
|
serum |
quantitative |
MTPL |
96 wells |
65,000 |
| HSV 2
IgG (Herpes Simplex Virus) |
EIA3487 |
60 min 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| HSV 2
IgG (Herpes Simplex Virus) (ref. sera opt., price on req.) |
EIA2801 |
20, 20, 10 RT |
|
serum 10uL |
qualitative |
MTPL |
96 wells |
73,000 |
| HSV 2
IgM |
EIA1794 |
90 min at RT |
|
serum |
quantitative |
MTPL |
96 wells |
67,000 |
| HSV 2
IgM (Herpes Simplex Virus) |
EIA3488 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| HSV 2
IgM (Herpes Stimplex Virus) (ref. sera opt., price on req.) |
EIA2802 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
MTPL |
96 wells |
73,000 |
| HSV 2
IgM CLA |
CLA5200 |
30min 37C / 30/15min. RT |
|
10 uL serum |
qualitative |
MTPL |
96 Wells |
71,000 |
| HTLV
1+2 (min order 2 kits) |
EIA1811 |
75 min. at 37 C. |
|
serum or plasma |
qualitative |
MTPL |
96 wells |
128,000 |
| HTLV
1+2 Ab (min 10 kits) |
EIA3905 |
45'/45' 37C, 15' RT |
pos./neg. control, qualit.
/ >98 % |
10 ul serum, plasma (human |
qualitative |
MTPL |
96 wells |
78,000 |
| HVA |
EIA1573 |
85 min. at RT |
0.125-10 mg/ml |
urine |
quantitative |
MTPL |
96 wells |
113,000 |
| I |
|
|
|
| IAA
(Insulin Autoantibody) |
EIA1593 |
16 hrs. at RT |
-/+ controls |
serum |
quantitative |
MTPL |
96 wells |
118,000 |
| IBR
Blocking AB, 3 steps high sensitivity |
EIA3160 |
|
|
|
|
VET. |
96 wells |
116,000 |
| ICA
(Intra-Cell Autoantibody) |
EIA1594 |
150 min. at RT |
-/+ controls |
serum |
qualitative |
MTPL |
96 wells |
154,000 |
| ICAM-1
(Intracellular Adhesion Molecule-1) or CD54 |
EIA1194 |
3 hrs. at RT |
0.3 ng/ml |
serum or plasma |
quantitative |
MTPL |
96 wells |
246,000 |
| IgA
Salivary Elisa |
SLV4636 |
60 / 15 min |
2.5 - 2500 ug/mL /// 0.5 ug/mL |
10 uL saliva |
quantitative |
MTPL |
96 wells |
88,000 |
| IgA-CIC
Elisa |
EIA3988 |
120/60/30 min |
controls qualitative |
200 ul serum, plasma |
qualitative |
MTPL |
96 wells |
88,000 |
| IgE
(Immunoglobulin E) (total) |
EIA1788 |
80 min. at RT |
|
serum |
quantitative |
MTPL |
96 wells |
59,000 |
| IGF 1
(equine) Elisa |
EIA3982 |
90/30 min |
0 - 1440 ng/ml /
8ng/ml |
50 ul heparin plasma or serum |
quantitative |
VET. |
96 wells |
323,000 |
| IGF
BP-1 (PP12) Elisa |
EIA3780 |
60'/15' |
0 - 50 ng/ml |
50 ul |
quantitative |
MTPL |
96 wells |
244,000 |
| IGF
BP-3 Elisa |
EIA3300 |
90/30 min |
360 - 6900 ng/ml // 10.5 ng/ml |
10 ul serum |
quantitative |
MTPL |
96 wells |
160,000 |
| IGF-1 -
600 quantitative Elisa |
EIA4140 |
120/60/30 min |
0 - 600 ng/mL / - |
50 ul serum |
quantitative |
MTPL |
96 wells |
94,000 |
| IGF-BP3
Elisa |
EIA5049 |
120 / 30 min |
460 - 16070 ng/ml /// 10 ng/ml |
10 uL serum |
quantitative |
MTPL |
96 wells |
160,000 |
| IgG
(mouse) Elisa |
EIA5052 |
60 / 30 / 10 min |
9,375 - 600 ng/ml /// - |
serum, plasma |
quantitative |
MTPL |
96 wells |
143,000 |
| IgG-CIC
Elisa |
EIA3986 |
120/60/30 min |
controls qualitative |
20 ul serum, plasma |
qualitative |
MTPL |
96 wells |
88,000 |
| IgM-CIC
Elisa |
EIA3987 |
120/60/30 min |
controls qualitative |
200 ul serum, plasma |
qualitative |
MTPL |
96 wells |
88,000 |
| Influenza
A IgA Elisa |
EIA4242 |
60 37C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| Influenza
A IgG Elisa |
EIA4238 |
60 37C, 30 / 15 min. RT |
pos. / neg control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| Influenza
A IgM Elisa |
EIA4240 |
60 37C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
65,000 |
| Influenza
B IgA Elisa |
EIA4239 |
60 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
65,000 |
| Influenza
B IgG Elisa |
EIA4241 |
60 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| Influenza
B IgM Elisa |
EIA4237 |
60 37C; 30/15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
65,000 |
| Insulin
(Bovine) Elisa |
EIA4748 |
120 / 15 min |
0.05 - 3 ug/L /// 0.025 ug/L |
25 uL serum / plasma |
quantitative |
MTPL |
96 wells |
228,000 |
| Insulin
(Canine) Elisa |
EIA4749 |
120 / 15 min |
0.02 - 1.5 ug/L /// 0.01 ug/L |
25 uL serum / plasma |
quantitative |
MTPL |
96 wells |
228,000 |
| Insulin
(Equine) Elisa |
EIA4746 |
120 / 15 min |
0.02 - 1.5 ug/L /// 0.01 ug/L |
25 uL serum / plasma |
quantitative |
MTPL |
96 wells |
246,000 |
| Insulin
(Feline) Elisa |
EIA4919 |
120 / 30 min |
5 - 700 ng/l /// 0.01 ug/L |
10 ul serum/ plasma |
quantitative |
MTPL |
96 wells |
228,000 |
| Insulin
(human) |
EIA1825 |
1 hour @ RT |
1.5 ulU/ml |
serum / plasma |
quantitative |
MTPL |
96 wells |
158,000 |
| Insulin
(human) |
EIA2935 |
1 hr RT |
1.5 iU/ml |
serum, plasma |
quantitative |
MTPL |
96 wells |
63,000 |
| Insulin
(mouse) EIA |
EIA3439 |
|
|
|
|
|
96 wells |
187,000 |
| Insulin
(mouse) ultrasensitive EIA |
EIA3440 |
120 / 30 min |
5ul sample: 0.22 - 7.1 ug/l,
50ul sample: 0.025 - |
5 ul or 50 ul mouse serum,
plasma or fluid |
quantitative |
MTPL |
96 wells |
198,000 |
| Insulin
(ovine) Elisa |
EIA4739 |
120 / 15 min |
0.05 - 3 ug/L /// 0.025 ug/L |
25 uL serum / plasma |
quantitative |
MTPL |
96 wells |
228,000 |
| Insulin
(Porcine) Elisa |
EIA4747 |
120 / 15 min |
0.02 - 1.5 ug/L /// 0.01 ug/L |
25 uL serum / plasma |
quantitative |
MTPL |
96 wells |
228,000 |
| Insulin
(porcine) high range Elisa |
EIA5126 |
60 / 15 min |
2.5 - 75 ug/l /// 0.313 ug/l |
10 ul serum, plasma |
|
|
96 wells |
251,000 |
| Insulin
(rat) |
EIA2048 |
60/15 min. |
0.15-5.5 ug/L |
25 ul serum, plasma |
quantitative |
MTPL |
96 wells |
160,000 |
| Insulin
(rat) ultrasensitive, ELISA |
EIA2943 |
|
|
|
|
|
96 wells |
173,000 |
| Insulin
(rat/mouse) |
EIA4127 |
120/30/15 min. |
0.2 - 10 ng/ml // 0.2 ng/ml'2 ng - 10 ng per ml |
20 ul serum, plasma |
quantitative |
MTPL |
96 wells |
185,000 |
| Insulin
anti- Elisa |
EIA3608 |
|
|
|
quantitative |
MTPL |
96 wells |
94,000 |
| Insulin
Iso ELISA |
EIA2336 |
60/15 min. |
3-100 mU/L |
|
|
|
96 wells |
158,000 |
| Insulin
rat high range ELISA |
EIA3985 |
120/15 min |
3 - 150 ug/l / 1.5ug/l |
10 ul serum, plasma |
quantitative |
MTPL |
96 wells |
160,000 |
| Insulin
Ultra-Sensitive |
EIA2337 |
60/15/min. |
0.15 - 10 mU/L |
50 ul serum, plasma |
|
|
96 wells |
171,000 |
| Interferon
/ Anti-IFN alpha (human) Elisa |
EIA4853 |
2 hrs / 1 hr / 10 min |
3.2 - 200 ng/mL /// 1.38 ng/mL |
20 ul cell culture, serum,
plasma, urine |
quantitative |
MTPL |
96 wells |
223,000 |
| Interferon
alpha (human) Elisa |
EIA4766 |
120 / 15 min |
8-500 pg/ml /// 3.16 pg/ml |
20 ul cell culture supernatants,
human serum, p |
quantitative |
MTPL |
96 wells |
217,000 |
| Interferon
beta |
EIA2088 |
|
|
|
|
|
96 wells |
415,000 |
| Interferon
gamma (porcine) Elisa |
EIA4828 |
1hr/ 1hr/ 30 min/10 min. at RT |
31-2000 pg/mL /// 3.3 pg/mL |
50 ul cell culture, serum,
plasma other biol. |
quantitative |
MTPL |
96 wells |
208,000 |
| Interferon
gamma (rat) - INF - |
EIA4582 |
120 / 60 / 45 min 37C / 20 min
RT |
21.8 - 1400 pg/mL // <13 pg/mL |
100 ul serum, plasma, buffered
solution, or cel |
quantitative |
MTPL |
96 wells |
325,000 |
| Interferon
gamma (rat) - INF - |
EIA4583 |
120 / 60 / 45 min 37C /
20 min RT |
21.8 - 1400 pg/mL // <13 pg/mL |
100 uL serum, plasma, buffered
solution, or cel |
quantitative |
MTPL |
192 wells |
500,000 |
| Interferon
gamma Elisa / CE |
EIA4434 |
120 / 15 min |
1 - 30 IU/ml // 0.03 IU/ml |
50 uL serum |
quantitative |
MTPL |
96 wells |
196,000 |
| Interferon
y (human) EIA |
EIA3277 |
120/15 min. at 24 C |
1 - 30 IU / ml |
50 ul human serum |
quantitative |
MTPL |
96 wells |
312,000 |
| Interferon
y (human) EIA |
EIA3278 |
120/15 min. at 24 C |
1-30 IU/ml |
50 ul human serum |
quantitative |
MTPL |
192 wells |
498,000 |
| Interferon
y (mouse) EIA |
EIA3378 |
3h/30min |
7.8 - 500 pg/ml |
100 ul serum and tissue culture
supernatant |
quantitative |
MTPL |
192 wells |
498,000 |
| Interferon
y (mouse) Elisa |
EIA3299 |
3h/30min |
7.8 - 500 pg/ml |
100 ul Serum, tissue culture
supernatant |
quantitative |
MTPL |
96 wells |
312,000 |
| Interferon
y (porcine) EIA |
EIA3178 |
incubation time: 3 hours |
7.8 500 pg/ml |
50 ul serum, plasma, cell
culture medium + 50 u |
quantitative |
MTPL |
96 wells |
312,000 |
| Interleukin
1 (alpha) EIA |
EIA3280 |
4 hours |
7.8 - 500 pg/ml |
50 ul rat serum |
quantitative |
MTPL |
96 wells |
312,000 |
| Interleukin
1 (beta) (mouse) |
EIA3379 |
2h/30 min |
15, 16 - 1000 pg/ml |
50 ul serum, tissue culture
supernatant |
quantitative |
MTPL |
192 wells |
498,000 |
| Interleukin
1 (beta) (mouse) Elisa |
EIA3302 |
2h/30 min |
15.16 - 1000 pg/ml |
50 ul Serum, tissue culture
supernatant |
quantitative |
MTPL |
96 wells |
312,000 |
| Interleukin
1 (beta) Elisa / CE |
EIA4437 |
120 / 15 min |
24 - 1166 pg/ml // 2 pg/ml |
200 uL serum |
quantitative |
MTPL |
96 wells |
196,000 |
| Interleukin
1- (human) Elisa |
EIA5154 |
120 / 60 / 10 min |
3.1 - 200 pg/ml /// 1.0 pg/ml |
100 ul cell culture supernatant
and serum, plas |
quantitative |
MTPL |
96 wells |
217,000 |
| Interleukin
1 alpha (human) Elisa |
EIA4839 |
2 hrs/ 1 hr / 10 min. at RT |
1.6 - 100 pg/mL /// 1.06 pg/mL |
50 ul cell culture, serum,
plasma (EDTA + citra |
quantitative |
MTPL |
96 wells |
223,000 |
| Interleukin
1 beta (rat) Elisa |
EIA4911 |
2hrs / 1 hr/ 10 min. at RT |
31.25-2000 pg/mL /// 4.4 pg/mL |
50 ul cell culture, serum,
plasma other biol. f |
quantitative |
MTPL |
96 wells |
208,000 |
| Interleukin
1 Receptor Antagonist (IL-1ra) Elisa |
EIA4500 |
2h / 1h/ 30 min. |
31.2-2000 pg/ml // 4pg/ml |
100 ul serum, plasma, cell
culture, other biol |
quantitative |
MTPL |
96 wells |
285,000 |
| Interleukin
10 |
EIA4699 |
4 h 30 min at RT |
11-1335 pg/ml /// 1 pg/ml |
100 uL serum |
quantitative |
MTPL |
96 wells |
196,000 |
| Interleukin
10 (mouse) |
EIA3380 |
4 h |
31.2-2,000 pg/ml |
100 ul serum, plasma, cell
culture supernatant |
quantitative |
MTPL |
192 wells |
498,000 |
| Interleukin
10 (mouse) Elisa |
EIA3298 |
4 h |
31.2-2,000 pg/ml |
100 ul Serum, Plasma, cell
culture supernatant |
quantitative |
MTPL |
96 wells |
344,000 |
| Interleukin
10 (porcine) EIA |
EIA3184 |
Incubation time: 3 hours |
7.8 - 500 ul/ml |
50 ul serum, plasma + 50 ul
diluent, 100 ul Cel |
quantitative |
MTPL |
96 wells |
344,000 |
| Interleukin
10 (porcine) EIA |
EIA3185 |
Incubation time: 3 hours |
7.8 - 500 pg/ml |
50 ul Serum, plasma + 50 ul
diluent, 100 ul cel |
quantitative |
MTPL |
192 wells |
498,000 |
| Interleukin
10 (rat) Elisa |
EIA3157 |
Incubation time: 3.5 hrs. in
total |
0-2000 pg/ml |
100ul Serum, Plasma |
quantitative |
MTPL |
96 wells |
312,000 |
| Interleukin
10 (rat) Elisa |
EIA3166 |
3.5 hrs. in total |
0-2000 pg/ml |
100ul Serum, Plasma |
quantitative |
MTPL |
192 wells |
498,000 |
| Interleukin
10 (rat) Elisa |
EIA4773 |
120 / 60/ 15 min |
15.6 - 1000 pg/ml /// 1.47 pg/ml |
50 ul cell culture supernatants,
human serum, j |
quantitative |
MTPL |
96 wells |
208,000 |
| Interleukin
12 (mouse) Elisa |
EIA4920 |
120/60/10 min |
31.25 - 2000 pg/mL /// 3.96 pg/mL |
50 ul cell culture, serum,
plasma other biol. f |
quantitative |
MTPL |
96 wells |
208,000 |
| Interleukin
12 +p40 Elisa |
EIA4698 |
4 h 30 min. at RT |
15 - 1300 pg/ml /// 1.5 pg/ml |
100 ul serum |
quantitative |
MTPL |
96 wells |
196,000 |
| Interleukin
12 p70 (rat) Elisa |
EIA4001 |
120/60/30/30 min |
7.8 - 500 pg/ml / <2.5 pg/ml |
100 ul cell extract |
quantitative |
MTPL |
96 wells |
418,000 |
| Interleukin
12p70 (human) Elisa |
EIA4843 |
2 hrs / 1 hr / 10 min. at RT |
3.2 - 200 pg/mL /// 2.11 pg/mL |
50 ul cell culture, serum,
plasma other biol. f |
quantitative |
MTPL |
96 wells |
223,000 |
| Interleukin
12p70 (mouse) Elisa |
EIA4842 |
2hrs / 1 hr/ 10 min at RT |
15.6 - 1000 pg/mL /// <10.0 pg/mL |
50 ul cell culture, serum,
plasma other biol. f |
quantitative |
MTPL |
96 wells |
208,000 |
| Interleukin
13 (human) Elisa |
EIA4841 |
1 nr/ 10 min |
1.56 - 100 pg/mL /// 0.73 pg/mL |
cell culture, serum, plasma
amniotic fluid, oth |
quantitative |
MTPL |
96 wells |
223,000 |
| Interleukin
13 (rat) |
EIA3391 |
120 / 30 / 30 min |
7.8 - 500 pg/mL // 1.5 pg/mL |
25 uL serum, plasma / 50 uL
buffered solution, |
quantitative |
MTPL |
192 wells |
498,000 |
| Interleukin
13 (rat) Elisa |
EIA3411 |
|
|
|
quantitative |
MTPL |
96 wells |
312,000 |
| Interleukin
15 (human) |
EIA3392 |
|
|
|
quantitative |
MTPL |
96 wells |
312,000 |
| Interleukin
15 (human) Elisa |
EIA3412 |
|
|
|
quantitative |
MTPL |
192 wells |
498,000 |
| Interleukin
16 (human) |
EIA3393 |
|
|
|
quantitative |
MTPL |
96 wells |
312,000 |
| Interleukin
17 A (human) Elisa |
EIA4840 |
2 hrs / 1 h/ 10 min |
1.6 - 100 pg/mL /// 0.5 pg/mL |
50 uL cell culture, serum,
plasma (citrate and |
quantitative |
MTPL |
96 wells |
329,000 |
| Interleukin
18 (rat) |
EIA4002 |
120/60/30/30 min at RT |
15.6 - 1000 pg/ml / < 4pg/ml |
100 ul serum, plasma, cell
culture med., buff. |
quantitative |
MTPL |
96 wells |
424,000 |
| Interleukin
18 (rat) |
EIA4059 |
120/60/30/30 min at RT |
15,6 - 1000pg/mL < 4 pg/mL |
100 ul serum, plasma, cell
culture med., buffer |
quantitative |
MTPL |
192 wells |
673,000 |
| Interleukin
2 (mouse) |
EIA3163 |
3.5 hrs. in total |
15 1000 pg/ml |
50ul Serum, Plasma |
quantitative |
MTPL |
192 wells |
498,000 |
| Interleukin
2 (mouse) Elisa |
EIA3155 |
3.5 hrs. in total |
15 - 1000 pg/ml |
50ul Serum, Plasma |
quantitative |
MTPL |
96 wells |
312,000 |
| Interleukin
2 (rat) |
EIA3381 |
|
|
|
quantitative |
MTPL |
192 wells |
498,000 |
| Interleukin
2 (rat) Elisa |
EIA5177 |
3h / 1h/ 10 min |
31.3 - 2,000 pg/ml /// 11 pg/ml |
50 ul cell culture supernatant,
serum (oth. bio |
quantitative |
MTPL |
96 wells |
204,000 |
| Interleukin
2 Elisa / CE |
EIA4436 |
120 / 15 min. |
0.78 - 23.8 U/ml // 0.05 U/ml |
100 uL serum |
quantitative |
MTPL |
96 wells |
196,000 |
| Interleukin
2 Receptor (human) Elisa |
EIA4835 |
3 hrs / 10 min |
0.31-20 ng/mL /// 0.27 ng/mL |
50 ul Cell culture, serum,
plasma, urine, other |
quantitative |
MTPL |
96 wells |
223,000 |
| Interleukin
23 (human) Elisa |
EIA5058 |
120 / 60 / 10 / 15 min |
78 - 5000 pg/mL /// 10 pg/mL |
50 ul cell culture supernatant
and serum or oth |
quantitative |
MTPL |
96 wells |
223,000 |
| Interleukin
4 (mouse) |
EIA3384 |
3 h / 15 min. |
15.6 - 1000 pg/ml |
50 ul serum tissue culture
supernatant |
quantitative |
MTPL |
192 wells |
498,000 |
| Interleukin
4 (mouse) Elisa |
EIA3291 |
3 h / 15 min |
15.6 - 1000 pg/ml |
50 ul Serum tissue culture
supernatant |
quantitative |
MTPL |
96 wells |
312,000 |
| Interleukin
4 (porcine) |
EIA4091 |
120/30/30 min. at RT |
0 - 1000 pg/mL // 2 pg/mL |
50 ul serum, plasma, cell
culture med., buffere |
quantitative |
MTPL |
192 wells |
498,000 |
| Interleukin
4 Elisa / CE |
EIA4435 |
120 / 30 min |
14.5 - 1696 pg/ml // 1.2 pg/ml |
100 uL serum |
quantitative |
MTPL |
96 wells |
196,000 |
| Interleukin
5 (human) Elisa |
EIA4832 |
2 hrs/ 1 hr/ 10 min. at RT |
7.8 - 500 pg/mL /// 1.45 pg/mL |
50 ul cell culture, serum,
plasma other biol. f |
quantitative |
MTPL |
96 wells |
223,000 |
| Interleukin
6 (human) |
EIA1200 |
150 min. at 37 C. |
7 pg/mL |
serum or plasma |
quantitative |
MTPL |
96 wells |
246,000 |
| Interleukin
6 (mouse) |
EIA3386 |
|
|
|
|
|
192 wells |
551,000 |
| Interleukin
6 (mouse) Elisa |
EIA3403 |
120 / 30 / 30 / 30 min |
7.8 - 500 pg/mL // <3 pg/mL |
50 ul serum, plasma / 100 uL
buffered solution, |
quantitative |
MTPL |
96 wells |
306,000 |
| Interleukin
6 (porcine) Elisa |
EIA1869 |
120 / 120 / 20 / 15 min |
125 - 4000 pg/mL /// -- |
100 ul serum |
quantitative |
MTPL |
96 wells |
75,000 |
| Interleukin
6 (rat) Elisa |
EIA3294 |
4 h |
31.2 - 2,000 pg/ml |
50 ul Serum, tissue culture
supernatant |
quantitative |
MTPL |
96 wells |
312,000 |
| Interleukin
6 (rat) Elisa |
EIA4845 |
2 hrs / 1 hr / 10 min. at RT |
31.3 - 2000 pg/mL /// 12 pg/mL |
50 ul cell culture, serum,
plasma other biol. f |
quantitative |
MTPL |
96 wells |
223,000 |
| Interleukin
6 Elisa / CE |
EIA4640 |
60 / 60/ 15 min |
23,3 - 2560 pg/ml /// 2 pg/ml |
100 ul serum |
quantitative |
MTPL |
96 wells |
196,000 |
| Interleukin
6 Receptor (human) Elisa |
EIA4844 |
3 hrs / 10 min |
8-500 ng/mL /// 0.01 ng/mL |
50 ul cell culture, serum,
plasma, amniotic flu |
quantitative |
MTPL |
96 wells |
223,000 |
| Interleukin
6 Receptor (mouse) EIA |
EIA3156 |
Incubation time: 3.5 hrs in
total |
15 2000 pg / ml |
100ul Serum, Plasma |
quantitative |
MTPL |
96 wells |
312,000 |
| Interleukin
6R hs (human soluble) |
EIA4423 |
120 / 30 / 30 min |
62,5 - 4000 pg/ml // <8 pg/ml |
20 ul serum / plasma |
quantitative |
MTPL |
96 wells |
314,000 |
| Interleukin
8 (human) |
EIA5193 |
60 / 60 / 30 / 15 min |
7.8 - 1000 pg/mL /// 0.64 pg/mL |
100 ul plasma, serum and tissue
culture superna |
quantitative |
MTPL |
96 wells |
183,000 |
| Interleukin
8 (porcine) EIA |
EIA3182 |
Incubation time: 4 hours |
31.2 - 2000 pg / ml |
50 ul Serum, plasma + 50 ul
diluent, 100 ul cel |
quantitative |
MTPL |
96 wells |
344,000 |
| Interleukin
8 (porcine) EIA |
EIA3183 |
Incubation time: 4 hours |
31.2 - 2000 pg/ml |
50 ul serum, plasma + 50
diluent, 100 ul Cell c |
quantitative |
MTPL |
192 wells |
546,000 |
| Interleukin
8 Elisa |
EIA4700 |
2 h 30 min at RT |
7-750 pg/ml /// 0.7 pg/ml |
100 uL serum |
quantitative |
MTPL |
96 wells |
192,000 |
| J |
|
|
|
| Japanese
Encephalitis IgG (JE) Elisa |
EIA4518 |
60/60 min. 37 C; 5/10/1 min RT |
- // 99 % |
4 ul serum (dilution 1:300) |
qualitative |
MTPL |
96 wells |
116,000 |
| JE
(Japanese Encephalitis) IgM Elisa |
EIA4505 |
60/60 min 37C; 5/10/1 min RT |
- // 99% |
4 uL serum |
qualitative |
MTPL |
96 wells |
116,000 |
| Jo-1
IgG |
EIA2787 |
10, 20, 10 RT |
|
serum, 10uL |
semi-quant. |
MTPL |
96 wells |
92,000 |
| Jo-1,
anti- Elisa |
EIA3581 |
|
|
|
quantitative |
MTPL |
96 wells |
99,000 |
| K |
|
|
|
| Kilham
Virus (rat) EcoElisa |
EIA4976 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Kilham
Virus (rat) EcoElisa |
EIA4977 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| L |
|
|
|
| L1-CAM
Elisa |
EIA5074 |
60 / 30 / 15 min. |
8.75 - 280 ng/ml /// 0.1 ng/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
189,000 |
| Lactoferrin,
anti- Elisa |
EIA3602 |
|
|
|
quantitative |
MTPL |
96 wells |
116,000 |
| LC -
Anti-LC-1 Elisa |
EIA4276 |
30/15/15/ min at RT |
0-300U/ ml // 1.0 U/ml |
10 ul serum, plasma (1:101
diluted) |
quantitative |
MTPL |
96 wells |
113,000 |
| LDL ox
EIA (oxidased low density lipoporteins) (sandwich) |
EIA3430 |
|
|
|
quantitative |
MTPL |
96 wells |
369,000 |
| LDL ox
Elisa (competitive) |
EIA4261 |
120 / 60 / 15 min |
0.5 - 9.7 U/l / < 0.3 U/l |
50 ul serum (1:41 diluted) |
quantitative |
MTPL |
96 wells |
369,000 |
| Legionella
IgG/IgM/IgA |
EIA2814 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
MTPL |
96 wells |
80,000 |
| Leishmania
Ab Canine Elisa |
EIA4796 |
? |
neg. / pos. control |
? |
qualitative |
VET. |
96 wells |
175,000 |
| Leptin
(human) (Sandwich EIA) |
EIA2395 |
120/30/30/15 min |
2 - 100 ng/ml // 1.0 ng/ml |
15 ul serum, plasma |
quantitative |
MTPL |
96 wells |
78,000 |
| Leptin
(mouse) Elisa |
EIA4564 |
2 h / 1 h / 30 min. |
0.2, 0.5, 1, 2, 5, 10, 20, 30
ng/ml // 0.05 ng/ |
25 or 50ul serum, plasma and
other biological m |
quantitative |
MTPL |
96 wells |
204,000 |
| Leptin
(mouse/rat) Elisa |
EIA4551 |
60/60/30/10 min. |
100 - 4000 pg / ml / 0.15 ng/ml |
7 ul serum, plasma and tissue
culture medium |
quantitative |
MTPL |
96 wells |
204,000 |
| Leptin
(rat) Elisa |
EIA4607 |
120/60/30/15 min |
0.2 - 30 ng/ml // 0.04 ng/ml |
10 ul serum, plasma and other
biological media |
quantitative |
MTPL |
96 wells |
204,000 |
| Leptin
Receptor Elisa human |
EIA3527 |
60 / 60 / 10 min |
2 - 100 ng/ml /// 1.2 ng/ml |
50 ul serum, plasma/ tissure
culture (diluted 1 |
quantitative |
MTPL |
96 wells |
282,000 |
| Leptospira
Hardjo antibodies, MCA based, cattle |
EIA2498 |
|
Positive and Negative Control |
|
|
VET. |
96 wells |
160,000 |
| LH
(Lutenizing Hormone) serum |
EIA1289 |
40 min. at RT |
10-200 mIU/ml |
serum |
quantitative |
MTPL |
96 wells |
61,000 |
| LH
(Lutenizing Hormone) urine |
EIA1290 |
40 min. at RT |
10-200 mIU/ml |
urine |
quantitative |
MTPL |
96 wells |
61,000 |
| LH
(Lutenizing Hormone-Releasing Hormone) (H - R - M - P) |
EIA1174 |
4 hrs. at RT |
0.02-0.05 ng/mL |
serum |
quantitative |
MTPL |
96 wells |
156,000 |
| LH Elisa |
EIA5221 |
10 / 60 / 10 min |
5-200 mlU/ml /// 1.0 mlU/ml |
25 ul serum |
qualitative |
MTPL |
96 wells |
59,000 |
| LIF-HILDA |
EIA3878 |
4h / 30 min |
300 - 3500 pg/mL 20pg/mL |
100 ul |
quantitative |
MTPL |
96 wells |
320,000 |
| Lipase
(pancreatic h-p-Lipase) Elisa |
EIA4459 |
30 / 15 min |
10 - 400 U/L / 5 U/L |
25 uL serum |
quantitative |
MTPL |
96 wells |
76,000 |
| Lipoprotein
(a) Lp (a) |
EIA4406 |
60/60/30 min. |
1 - 165 mg/dL // / |
100 ul serum, plasma (diluted
1:500) |
quantitative |
MTPL |
96 wells |
107,000 |
| Liver
Screen Blot (16 strips = unit) |
DOT5120 |
5 / 60 / 30 / 10 min |
on strip |
10 ul serum |
strip |
Immunoblot |
16 strips |
124,000 |
| Liver
Screen Blot (8 strips = units) |
DOT5119 |
5 / 60 / 30 / 10 min |
on strip |
10 ul serum |
strip |
Immunoblot |
8 strips |
90,000 |
| LKM -
Anti-LKM-1 Elisa |
EIA4277 |
30/15/15 min at RT |
0-300U/ ml // 1.0 U/ml |
10 ul serum, plasma (1:101)
diluted) |
quantitative |
MTPL |
96 wells |
113,000 |
| LL-37
(human) Elisa |
EIA5140 |
60/60/60/20-30 min |
0.1 to 100 ng/ml. /// 0.1 ng/ml. |
100 ul plasma (EDTA) and cell
culture supernata |
quantitative |
MTPL |
2x96 wells |
462,000 |
| Lymphoc.
Choriomeningitis V. (guinea pig) EcoElisa |
EIA4982 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Lymphoc.
Choriomeningitis V. (guinea pig) EcoElisa |
EIA4983 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Lymphoc.
Choriomeningitis V. (hamster) EcoElisa |
EIA4984 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1;60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Lymphoc.
Choriomeningitis V. (hamster) EcoElisa |
EIA4985 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Lymphoc.
Choriomeningitis V. (mouse) EcoElisa |
EIA4978 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Lymphoc.
Choriomeningitis V. (mouse) EcoElisa |
EIA4979 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Lymphoc.
Choriomeningitis V. (rat) EcoElisa |
EIA4980 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Lymphoc.
Choriomeningitis V. (rat) EcoElisa |
EIA4981 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Lypocheck
Immunoassay tri-level control |
EIA2979 |
|
|
|
|
|
12x5ml |
170,000 |
| Lysozyme
anti- Elisa |
EIA3601 |
|
|
|
quantitative |
MTPL |
96 wells |
116,000 |
| M |
|
|
|
| Malaria
Ab Elisa (min. 10 kits) |
EIA5048 |
60 / 30 / 30 / 30 min |
pos. + neg. control /// >95 % |
150 uL serum |
qualitative |
MTPL |
192 wells |
95,000 |
| Malaria
Elisa |
EIA4263 |
30 / 30 min 37 C; 30 min RT |
neg. / pos. control,
qualitative // 92.5 - 100 % |
50 ul serum, plasma |
qualitative |
MTPL |
96 wells |
132,000 |
| MCP-1
(human) Elisa |
EIA4857 |
2 hrs / 10 m in. at RT |
16 - 1000 pg/mL /// 2.31 pg/mL |
100 ul cell culture, serum,
plasma, amniotic fl |
quantitative |
MTPL |
96 wells |
223,000 |
| MCP-1
(mouse) Elisa |
EIA5091 |
120/60/10 min. |
15.6 - 1000 pg/mL /// 2.2 pg/mL |
50 ul Cell culture supernatant
and serum or oth |
quantitative |
MTPL |
96 wells |
208,000 |
| Measles
IgG |
EIA3495 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Measles
IgM |
EIA3496 |
60 min. 37 C; 30 / 15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
76,000 |
| Melatonin |
EIA1431 |
overnight at 2-8 C |
2.6 pg/ml |
serum or plasma |
quantitative |
MTPL |
96 wells |
215,000 |
| Melatonin
(direct) Saliva Elisa |
SLV4779 |
16-20 hrs 2-8 C, 2 / 1 h/ 15
min. Rt |
0.5 - 50 pg/mL /// 0.3 pg/mL |
100 ul Saliva |
quantitative |
MTPL |
96 wells |
234,000 |
| Melatonin
Sulfate |
EIA1432 |
150 min. at RT |
1 ng/ml |
urine |
quantitative |
MTPL |
96 wells |
249,000 |
| Meningitis
IgG Elisa (min. 10 kits) |
EIA4918 |
60/60 min. 37 C / 20 min RT |
pos./neg control /// --- |
10 ul serum/plasma |
qualitative |
MTPL |
96 wells |
94,000 |
| Met
Combi Plasma Elisa |
EIA4865 |
16-20h 2-8C, 90/15-30 min RT |
Metanephrine 40-5275 pg/mL,
Normetaneph.: 33-5906 |
300 ul plasma |
quantitative |
MTPL |
2 x 96 wells |
301,000 |
| Metanephrine |
EIA2748 |
90/15/60/30/40 min. |
26-2500 ug/L // 8.6 ug/L |
10 ul urine |
quantitative |
MTPL |
96 wells |
173,000 |
| Metanephrine
Plasma Elisa |
EIA4313 |
overnight |
15-3,000pg/ml // 7.5pg/ml |
plasma |
quantitative |
MTPL |
96 wells |
204,000 |
| Metanephrine
urine Elisa |
EIA4315 |
2 hours |
15 - 1,500ng/ml // 7.5ng/ml |
urine |
quantitative |
MTPL |
96 wells |
149,000 |
| MetCombi
(plasma) (Methanephrine/Normetanephrine) Elisa |
EIA4082 |
15-20h/30/20-30 min |
norm: 0-10000 pg/ml, meth:
0-6000 pg/ml, / meth:10 |
500 ul plasma |
quantitative |
MTPL |
2 x 96 wells |
285,000 |
| MetCombi
Elisa (Methanephrine/Normetanphrine) |
EIA4083 |
30/30/15-20 min |
norm: 0-6000ng/ml, meth:
0-2000ng/ml, / meth:11 ng |
10 ul urine |
quantitative |
MTPL |
2 x 96 wells |
200,000 |
| Microalbumin |
EIA2361 |
|
|
|
quantitative |
MTPL |
96 wells |
84,000 |
| Microalbumin Elisa |
EIA3881 |
30'/15' RT |
0.15 - 400 ug/ml 0.5 ug/ml |
20 ul urine |
quantitative |
MTPL |
96 wells |
94,000 |
| Microglobulin
Alpha-1 |
EIA5100 |
1h; 30min; 3 x 1h; 15min |
0.019-1.5 mg/l /// 0.006 mg/l. |
10 ul serum, plasma, urine |
|
|
96 wells |
168,000 |
| Microglobulin,
(anti-beta2) Elisa |
EIA3609 |
|
|
|
quantitative |
MTPL |
96 wells |
94,000 |
| Microglobulin,
(beta-2) |
EIA1789 |
1 hr. at 37 C. |
0.2 ug/ml |
serum |
quantitative |
MTPL |
96 wells |
71,000 |
| Milk
stabilisation kit incl. sterile test tubes (bovine) |
EIA3162 |
|
|
|
|
VET. |
50 tests |
upon req. |
| Minute
Virus (mouse) EcoElisa |
EIA4986 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Minute
Virus (mouse) EcoElisa |
EIA4987 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| MIP-1
beta (human) (Macrophage Inflammatory Protein-1b) |
EIA3788 |
4h |
15.6-1000 pg/ml 2pg/ml |
50 ul |
quantitative |
MTPL |
96 wells |
287,000 |
| MIP-2
(rat) (Macrophage Inflammatory Protein-2) |
EIA3789 |
3h / 30' |
10-640 pg/ml <1pg/ml |
50 ul |
quantitative |
MTPL |
96 wells |
312,000 |
| MIP-5
(human) (Macrophage Inflammatory Protein-5) |
EIA3790 |
3h |
7.8-500 pg/ml < 1 pg/ml |
10 ul (1:20) |
quantitative |
MTPL |
96 wells |
301,000 |
| Mitochondria |
EIA4143 |
RT 45 min. RT |
|
serum |
quantitative |
MTPL |
96 wells |
95,000 |
| MMP-1
(human) Elisa |
EIA5162 |
150/60/45/30 min |
24.69-18000 pg/ml /// 8 pg/ml |
100 ul cell culture
supernatants, serum, plasma |
quantitative |
MTPL |
96 wells |
344,000 |
| MMP-13
(human) Elisa |
EIA4862 |
2 hrs / 1 hr/ 20 min. at RT |
0.31 - 20 ng/mL /// 0.18 ng/mL |
50 ul dil. cell culture
supernatant, serum and |
quantitative |
MTPL |
96 wells |
223,000 |
| MMP-9
(human) Elisa |
EIA4861 |
1 hr / 10 min. at RT |
0.23 - 15 ng/mL /// 0.05 ng/mL |
10 ul dil. cell culture
supernatant, serum and |
quantitative |
MTPL |
96 wells |
223,000 |
| Morphine
(serum/blood) Elisa |
EIA4923 |
30 / 15 min |
1 - 100 ng/ml /// - |
10 ul serum, whole blood |
quantitative |
MTPL |
96 wells |
141,000 |
| Morphine
(serum/blood) Elisa |
EIA4924 |
30/15 min |
1-100 ng/ml /// - |
10 ul serum, whole blood |
quantitative |
MTPL |
480 wells |
449,000 |
| Morphine
(urine) Elisa |
EIA4925 |
30 / 30 min |
5-100 ng/ml /// / |
10 ul urine |
quantitative |
MTPL |
96 wells |
141,000 |
| Morphine
(urine) Elisa |
EIA4926 |
30 / 30 min |
5-100 ng/ml /// - |
10 ul urine |
quantitative |
MTPL |
480 wells |
449,000 |
| MPO
(Myeloperoxidase) Elisa |
EIA4571 |
60 / 60 / 15 min |
3 - 300 ug/l // < 3 ug/l |
25 ul serum / plasma |
quantitative |
MTPL |
96 wells |
354,000 |
| MPO
(Myeloperoxidase) IgG (pANCA) |
EIA2776 |
20, 20, 10, RT |
|
serum, 10uL |
semi-quant. |
MTPL |
96 wells |
78,000 |
| MPO
(pANCA) anti- Elisa |
EIA3597 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| MSH
(alpha) (Melanocyte Stimulating Hormone) (human - rat - mouse) |
EIA2951 |
|
|
|
quantitative |
MTPL |
96 wells |
177,000 |
| Mumps
IgG |
EIA3497 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Mumps
IgM |
EIA3498 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Mycoplasma
hominis IgA |
EIA5097 |
60/30/15 min RT |
neg., cut-off, pos. control |
10 uL serum |
qualitative |
MTPL |
96 wells |
80,000 |
| Mycoplasma
hominis IgG Elisa |
EIA4559 |
60 / 30 / 15 min. at RT |
pos./neg. / cut-off control |
10 ul serum, plasma |
qualitative |
MTPL |
96 wells |
84,000 |
| Mycoplasma
IgG (ref. sera opt., price on req.) |
EIA2812 |
20, 20, 10 RT |
|
serum: 10ul |
qualitative |
MTPL |
96 wells |
80,000 |
| Mycoplasma
IgM (ref. sera opt., price on req.) |
EIA2813 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
MTPL |
96 wells |
82,000 |
| Mycoplasma
pneumoniae IgG |
EIA3499 |
60 min. 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Mycoplasma
pneumoniae IgM |
EIA3500 |
60 min. 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Mycoplasma
pulmonis (hamster) EcoElisa |
EIA4992 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Mycoplasma
pulmonis (hamster) EcoElisa |
EIA4993 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Mycoplasma
pulmonis (mouse) EcoElisa |
EIA4988 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Mycoplasma
pulmonis (mouse) EcoElisa |
EIA4989 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Mycoplasma
pulmonis (rat) EcoElisa |
EIA4990 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Mycoplasma
pulmonis (rat) EcoElisa |
EIA4991 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Myoglobin |
EIA3955 |
|
12 to 90ng/ml // 5ng/ml |
serum and plasma |
quantitative |
MTPL |
96 wells |
71,000 |
| Myositis
Screen Blot (16 strips = unit) |
DOT5122 |
5 / 60 / 30 / 10 min |
on strip |
10 ul serum |
strip |
Immunoblot |
16 strips |
124,000 |
| Myositis
Screen Blot (8 strips = unit) |
DOT5121 |
5 / 60 / 30 / 10 min |
on strip |
10 ul serum |
strip |
Immunoblot |
8 strips |
90,000 |
| N |
|
|
|
| Neopterin |
EIA2949 |
|
|
|
|
|
96 wells |
185,000 |
| Neopterin
Elisa |
EIA1476 |
|
|
|
quantitative |
MTPL |
96 wells |
133,000 |
| Neopterin
Elisa |
EIA4366 |
60 / 30 min. |
1.35 - 111 nmol/L // 0.32 nmol/L |
10 ul serum |
quantitative |
MTPL |
480 wells |
709,000 |
| Nitrotyrosine
(Plasma) Elisa |
EIA5168 |
150 / 60 / 10-20 min |
0 - 1250 nM/L /// / |
50 ul EDTA plasma |
quantitative |
MTPL |
96 wells |
304,000 |
| Noradrenalin
(Norepinephrine) |
EIA2049 |
14-20 h 120/120/20 min. |
5-500 ng/ml |
20 ul urine (extraction) |
quantitative |
MTPL |
96 wells |
190,000 |
| Noradrenalin
Research Elisa |
EIA4706 |
Acylation: 55 min. EIA:
30/120/30 min |
8 - 2048 pg/sample /// 2.7 pg/sample |
1-100 uL tissue extracts,
dialysates, small amt |
quantitative |
MTPL |
96 wells |
228,000 |
| Noradrenaline
Elisa |
EIA4317 |
3,5 hours |
4-1,024mg/ml // urine: 2ng/ml , plasma: 67pg/ml |
plasma, urine |
quantitative |
MTPL |
96 wells |
204,000 |
| Normetanephrine
plasma Elisa |
EIA4319 |
overnight |
30 - 6,000 pg/ml // 15pg/ml |
plasma |
quantitative |
MTPL |
96 wells |
204,000 |
| Normetanephrine
urine Elisa |
EIA4321 |
2 hours |
40-4,000ng/ml // 20ng/ml |
urine |
quantitative |
MTPL |
96 wells |
149,000 |
| Normethanephrine |
EIA2749 |
90/15/60/30/20 min |
77-7500 ug/L // 12 ug/L |
10 ul Urine |
quantitative |
MTPL |
96 wells |
190,000 |
| Norovirus
(stool) Elisa |
EIA4864 |
60 / 30 / 15 min |
neg. and pos. control /// 93.3 |
100 ul or 50 -100 mg stool |
qualitative |
MTPL |
96 wells |
289,000 |
| NSE |
EIA4424 |
60 / 30 min |
5 - 200 ug/L // 1ug/L |
25 uL serum |
quantitative |
MTPL |
96 wells |
90,000 |
| NSE
(Neuron specific Enolase) (controls to be ordered extra EIA4458) |
EIA2353 |
|
|
|
quantitative |
MTPL |
96 wells |
126,000 |
| NSE
Elisa (controls included) |
EIA4610 |
60 / 15 min |
4 - 100 ng/mL // 4 ng/mL. |
25 uL serum |
quantitative |
MTPL |
96 wells |
99,000 |
| NT-proBNP
direct Elisa |
EIA4827 |
3h / 30 min |
10-640 fmol/ml /// 3 fmol/ml |
50 ul serum, plasma |
quantitative |
MTPL |
96 wells |
306,000 |
| Nucleo
Screen Blot (16 strips = unit) |
DOT5124 |
5 / 60 / 30/ 10 min |
on strip |
10 ul serum |
strip |
Immunoblot |
16 strips |
111,000 |
| Nucleo
Screen Blot (8 strips = unit) |
DOT5123 |
5 / 60 / 30 / 10 min |
on strip |
10 ul serum |
strip |
Immunoblot |
8 strips |
78,000 |
| O |
|
|
|
| OPG
(rat/mouse) Elisa |
EIA5155 |
120/120/20/20 min |
0-4000 pg/ml /// - |
100 ul serum, plasma, urine and
cell culture su |
quantitative |
MTPL |
96 wells |
730,000 |
| Opiates
(serum/blood) Elisa |
EIA4928 |
30 / 30 min |
5 - 500 ng/ml /// - |
25 ul serum, whole blood |
quantitative |
MTPL |
480 wells |
449,000 |
| Opiates
(urine) Elisa |
EIA4922 |
30 / 30 min |
50-1000 ng/ml /// --- |
25 ul urine |
quantitative |
MTPL |
480 wells |
449,000 |
| Opiates
(urine) Elisa |
EIA4929 |
30 / 30 min |
50 - 1000 ng/ml /// - |
25 ul urine |
quantitative |
MTPL |
96 wells |
141,000 |
| Osteocalcin
(mouse) |
EIA4010 |
18-24h/30/15 min |
1 - 50 ng/ml, quantit / |
5-10 ul serum |
quantitative |
MTPL |
96 wells |
209,000 |
| Osteocalcin
(rat) |
EIA2095 |
|
|
|
quantitative |
MTPL |
96 wells |
208,000 |
| Osteocalcin
intact (human) |
EIA1735 |
3 hrs. at RT |
0.78 ng/ml |
Plasma |
quantitative |
MTPL |
96 wells |
213,000 |
| Osteocalcin
intact EIA |
EIA3375 |
120/30 min. |
2-90 pg/ml |
25 ul serum, plasma |
quantitative |
MTPL |
96 wells |
171,000 |
| Osteocalcin
mid-tact, (human) |
EIA1733 |
2 hrs. at 20 C. |
0.4 ng/ml |
Serum or Plasma |
quantitative |
MTPL |
96 wells |
196,000 |
| Osteopontin
(mouse) Elisa |
EIA4933 |
60 min 37 C, 30 min 4 C, 30 min
RT |
1 - 64 ng/ml /// 0.15 ng/ml |
100 ul urine, EDTA plasma and
cell culture supe |
quantitative |
MTPL |
96 wells |
411,000 |
| Osteopontin
(rat) Elisa |
EIA4934 |
60 min. 37 C, 30 min. 4 C, 30
min RT |
0.07 - 4.75 ng/ml /// 0.01 ng/ml |
100 ul urine, EDTA plasma and
cell culture supe |
quantitative |
MTPL |
96 wells |
411,000 |
| Osteoprotegerin
(human) Elisa |
EIA4573 |
60 / 60 / 30 / 10 min |
1.5 - 60 pmol/l // 0.13 pmol/l |
50 ul serum, plasma, synovial
fluid and tissue |
quantitative |
MTPL |
96 wells |
306,000 |
| Osteoprotegerin
(OPG) |
EIA3551 |
|
|
|
quantitative |
MTPL |
96 wells |
449,000 |
| Ovarian
(anti-Ovarian Ab) |
EIA2937 |
60/60/30 min. @ RT |
n/a |
serum |
quantitative |
MTPL |
96 wells |
105,000 |
| Ovarian
Ab Ig-Typing Elisa |
EIA3777 |
|
|
|
quantitative |
MTPL |
96 wells |
154,000 |
| P |
|
|
|
| P-ANCA,
Elisa |
EIA2579 |
|
|
|
|
|
96 wells |
202,000 |
| Pancreatic
Peptide Elisa |
EIA4639 |
2h/1h/1h RT |
0-100 ng/ml /// / |
50 ul plasma |
qunatitative |
MTPL |
96 wells |
177,000 |
| Pankrin
Elisa |
EIA3781 |
|
|
|
quantitative |
MTPL |
96 wells |
304,000 |
| PAP
(Prostatic Acid Phosphate) |
EIA1566 |
40 min at RT |
1-30 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
82,000 |
| PAP
Complex (Plasmin alpha-2 Antiplasmin Complex) |
EIA3763 |
20'/20'/15' |
50 - 5000 ug/l /
50 ug/l |
plasma 50 ul |
quantitative |
MTPL |
192 wells |
143,000 |
| PAP
micro 2000 Elisa |
EIA5084 |
30/30/15 min |
50-2000 ug/L /// 10 ug/L |
50 ul plasma |
quantitative |
MTPL |
192 wells |
234,000 |
| PAPP-A -
60 Elisa |
EIA4889 |
30/30/15 min |
2.0 - 60.0 ug/ml /// 0.034 ug/ml |
20 ul serum, plasma |
quantitative |
MTPL |
96 wells |
73,000 |
| PAPP-A
(human) <EIA2397(a)> |
EIA2397 |
30/30/15 min |
1.0 - 30.0 ug/ml /// 0.133 ug/ml |
10 ul serum, plasma |
quantitative |
MTPL |
96 wells |
69,000 |
| PAPP-A
US (ultra sensitive) Elisa |
EIA4512 |
60 / 60/ 30 / 15 min |
11.25 - 450 ng/ml / 0.023 ng/ml |
100 ul serum |
quantitative |
MTPL |
96 wells |
107,000 |
| Parainfluenza
1,2,3 IgA - |
EIA3871 |
60 min 37 C /
30/15 min. RT |
pos./neg./cut-off control // >90 % |
10 uL serum |
qualitative |
MTPL |
96 wells |
92,000 |
| Parainfluenza
1/2/3 IgA, Elisa |
EIA4351 |
60 / 30 / 20min. RT |
pos./neg. control // - |
100 ul serum, plasma (diluted
1:101) |
qualitative |
MTPL |
96 wells |
105,000 |
| Parainfluenza
1/2/3 IgG Elisa |
EIA4349 |
60 / 30 / 20 min. RT |
pos./neg. control // - |
100 ul serum, plasma (diluted
1:101) |
qualitative |
MTPL |
96 wells |
105,000 |
| Parainfluenza
1/2/3 IgM, Elisa |
EIA4350 |
60 / 30 / 20 min RT |
pos./neg control // - |
100 ul serum, plasma (diluted
1:101) |
qualitative |
MTPL |
96 wells |
105,000 |
| Parainfluenza
3 (PI3) Bovine Elisa |
EIA4429 |
60/60 min 37 C; 10 min RT |
pos. samples; qualitative test |
10 ul bovine serum |
qualitative |
MTPL |
96 tests |
132,000 |
| Parainfluenza
Virus-5 (PI5) IgG antibodies (canine) |
EIA2491 |
60/60/20 min. |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
VET. |
96 wells |
160,000 |
| Parietal
cell, anti- Elisa |
EIA3607 |
|
|
|
quantitative |
MTPL |
96 wells |
109,000 |
| Parvovirus
B 19 IgG |
EIA3503 |
60 min 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
94,000 |
| Parvovirus
B 19 IgM |
EIA3504 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
105,000 |
| Parvovirus
IgG (w/o controls) |
EIA4328 |
|
|
|
quantitative |
MTPL |
96 wells |
280,000 |
| Parvovirus
IgM (w/o controls) |
EIA4329 |
|
|
|
quantitative |
MTPL |
96 wells |
280,000 |
| Parvovirus-1
(mouse) EcoElisa |
EIA4994 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Parvovirus-1
(mouse) EcoElisa |
EIA4995 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Parvovirus-1
(rat) EcoElisa |
EIA4996 |
30 / 30 / 20 min. |
pos. + neg. control ///- |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Parvovirus-1
(rat) EcoElisa |
EIA4997 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Pepsinogen
I Elisa |
EIA4604 |
60 / 20 min |
3 - 300 ng/ml /// 0.5 ng/ml |
25 ul serum |
quantitative |
MTPL |
96 wells |
135,000 |
| Pepsinogen
II Elisa |
EIA4603 |
120 / 20 min |
6.3 - 100 ng/ml /// 0.5 ng/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
135,000 |
| PGE2
Enzyme Immunoassay High Sensitive |
EIA5203 |
15 min. RT / 16h 4c / 30 min RT |
12.5 - 400 pg/ml /// 10.9 pg/mL |
100 ul saliva, urine, serum,
EDTA and Heparin P |
quantitative |
MTPL |
96 wells |
124,000 |
| Phenylalanine
(PKU) neonatal Screening Assay (25 plates x 96) |
ENZ4743 |
30 / 30 min |
1 - 18 mg/dL /// - |
newborn's heel blood |
quantitative |
Enzymatic |
2400 wells |
293,000 |
| Phenylalanine
(PKU) neonatal Screening Assay (5 plates x 96) |
ENZ4502 |
30 / 30 min |
1 - 18 mg/dL // - |
newborn's heel blood |
quantitative |
Enzymatic |
480 wells |
109,000 |
| Phenylalanine
(with Membrane Plate) |
EIA1479 |
105 min at RT |
0.2 mg/dL |
blood |
quantitative |
MTPL |
960 wells |
314,000 |
| Phenylalanine
(without Membrane Plate) |
EIA1480 |
105 min. at RT |
0.2 mg/dl. |
blood |
quantitative |
MTPL |
960 tests |
236,000 |
| Phenylalanine
neonate (with Membrane Plate) |
EIA1477 |
105 min at RT |
0.2 mg/dL |
blood |
quantitative |
MTPL |
192 wells |
111,000 |
| Phenylalanine
neonate (without Membrane Plate) |
EIA1478 |
105 min at RT |
0.2 mg/dL |
blood |
quantitative |
MTPL |
192 wells |
94,000 |
| Phosphatidic
Acid IgG/IgM, anti Elisa |
EIA3594 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| Phosphatidyl
Inositol IgG/IgM, anti- Elisa |
EIA3593 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| Phosphatidyl
Serine Ab IgG/IgM, Elisa |
EIA2580 |
|
|
|
|
|
96 wells |
194,000 |
| Phosphatidyl
Serine IgG/IgM, anti- Elisa |
EIA3592 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| Phospholipid
Screen IgG/IgM, anti- Elisa |
EIA3591 |
|
|
|
quantitative |
MTPL |
96 wells |
105,000 |
| PIIANP
Elisa (Type IIA Collagen N-Propeptide) |
EIA4446 |
120 / 30 / 30 min |
4.69 - 150 ng/ml // 1.076 ng/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
244,000 |
| PLGF
(Placenta like growth factor) |
EIA4529 |
60/60/30/30 min |
0-1000 pg/ml // 2,258 pg/ml |
urine / serum |
quantative |
MTPL |
96 wells |
122,000 |
| PLTP
Acitivity (Plasma phospholipid transfer protein) |
EIA4415 |
30 - 60 min 37 C |
yes / - |
1 - 3 ul serum / plasma |
qualitative |
Activ. A. |
100 tests |
371,000 |
| PMN
Elastase (human) Elisa |
EIA4856 |
1 hr / 1 hr / 20 min at RT |
0.156-10 ng/mL /// 1.98 ng/mL |
5/10 ul (1:100 dil.) cell cult.,
plasma, exucat |
quantitative |
MTPL |
96 wells |
223,000 |
| PMSG
(Pregnant Mare Serum Gonadotropin) |
EIA1298 |
130 min. at RT |
On Request |
serum |
quantitative |
VET. |
96 wells |
75,000 |
| PMSG
semiquantitative |
EIA5135 |
60/60/30 min |
neg., cut-off, pos. control /// - |
3 drops serum or plasma |
qualitative |
MTPL |
96 wells |
86,000 |
| Pneumonia
Virus (guinea pig) EcoElisa |
EIA5002 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Pneumonia
Virus (guinea pig) EcoElisa |
EIA5003 |
30 / 30 / 20 min. |
pos. + neg. control |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Pneumonia
Virus (hamster) EcoElisa |
EIA5004 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Pneumonia
Virus (hamster) EcoElisa |
EIA5005 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Pneumonia
Virus (mouse) EcoElisa |
EIA4998 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Pneumonia
Virus (mouse) EcoElisa |
EIA4999 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Pneumonia
Virus (rat) EcoElisa |
EIA5000 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Pneumonitis
Virus (mouse) EcoElisa |
EIA5006 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Pneumonitis
Virus (mouse) EcoElisa |
EIA5007 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Polio
Virus (mouse) EcoElisa |
EIA5008 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Polio
Virus (mouse) EcoElisa |
EIA5009 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 Wells |
358,000 |
| Polio
Virus (rat) EcoElisa |
EIA5010 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Polio
Virus (rat) EcoElisa |
EIA5011 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Polyoma
Virus (mouse) EcoElisa |
EIA5012 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Polyoma
Virus (mouse) EcoElisa |
EIA5013 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| PR3
IgG (CANCA) (Proteinase-3) |
EIA2778 |
20, 20, 10 RT |
|
serum, 10uL |
semi-quant. |
MTPL |
96 wells |
82,000 |
| Pregnenolon
Serum Elisa |
EIA4912 |
60 / 30 / 15 min |
0.1 - 25.6 ng/ml /// 0.054 ng/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
82,000 |
| Pregnenolone |
EIA4170 |
60/15/ min |
0,1 - 25,6 ng/ml // 0.05 ng/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
80,000 |
| Progesterone |
CLA4656 |
60 / 10 min |
0.1 - 60 ng/ml |
25 ul serum |
quantitative |
MTPL |
96 wells |
80,000 |
| Progesterone |
EIA1561 |
75 min. at RT |
0.3-20 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
61,000 |
| Progesterone |
SLV2931 |
60 / 15 min |
10 - 5000 pg/ml // 5.5 pg/ml |
25 ul saliva |
quantitative |
MTPL |
96 wells |
73,000 |
| Progesterone
(serum) CLA |
CLA4663 |
min |
|
serum |
quantitative |
MTPL |
96 wells |
65,000 |
| Progesterone
/ 17a Hydroxy-Progesterone (serum) CLA |
CLA4665 |
min |
|
serum |
quantitative |
MTPL |
96 wells |
69,000 |
| Progesterone,
17 a-Hydroxy- |
EIA1292 |
90 min. at RT |
0.15-20 ng/ml |
serum (saliva) |
quantitative |
MTPL |
96 wells |
63,000 |
| Progesterone,
17 a-Hydroxy- (salivary) |
SLV3140 |
60/15 min |
5 - 5000 pg/ml // 3 pg/ml |
25 ul saliva |
quantitative |
MTPL |
96 wells |
73,000 |
| Proinsulin
intact (Control sera lyophilized 2 levels, 2 x 1 ml included) |
EIA1560 |
270 min. at RT. |
2-100 pmol/L |
serum, plasma |
quantitative |
MTPL |
96 wells |
76,000 |
| Proinsulin
total (human) |
EIA4156 |
60/60/30 min |
2 - 200 pM / 0.5 pM |
20 ul serum and plasma |
quantitative |
MTPL |
96 wells |
215,000 |
| Prolactin |
CLA4729 |
30 min |
5-200 ng/ml /// 0.3 ng/ml |
25 ul serum |
quantitative |
MTPL |
96 wells |
86,000 |
| Prolactin |
EIA1291 |
40 min. at RT |
5-200 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
61,000 |
| Prolactin
(rat) Elisa |
EIA4493 |
180 / 30 min |
2.25 - 180 ng/ml // 0.36 ng/ml |
10 uL serum / plasma |
quantitative |
VET |
96 wells |
323,000 |
| Prolactin
Elisa |
EIA5220 |
15 / 30 / 10 min |
5-200 ng/ml /// 1.0 ng/ml |
10 ul serum |
quantitative |
MTPL |
96 wells |
59,000 |
| Prostaglandin
E2 (PGE2) Elisa |
EIA5194 |
120 / 30 min |
31.25 - 1000 pg/ml /// 29.1 pg/mL |
100 ul Saliva, Urine, Serum,
EDTA and Heparin P |
quantitative |
MTPL |
96 wells |
124,000 |
| Prothrombin
IgA anti- Elisa |
EIA3613 |
|
|
|
quantitative |
MTPL |
96 wells |
114,000 |
| Prothrombin
IgG/IgM, anti- Elisa |
EIA3612 |
|
|
|
quantitative |
MTPL |
96 wells |
114,000 |
| Prothrombin
Screen, anti- |
EIA3614 |
|
|
|
quantitative |
MTPL |
96 wells |
114,000 |
| PSA
(Prostate Specific Antigen) |
EIA1778 |
2 hrs. at RT |
0.5 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
65,000 |
| PSA
(Prostate Specific Antigen) |
EIA4105 |
|
|
|
quantitative |
MTPL |
96 wells |
63,000 |
| PSA
free |
EIA1792 |
2 hrs. at RT |
0.05 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
71,000 |
| PSA
free |
EIA4189 |
60/60/15 min |
0.75 - 12 ng/ml /
0.1 nng/ml |
25ul serum |
quantitative |
MTPL |
96 wells |
65,000 |
| PSA
total |
EIA3719 |
1.5 hrs |
1.56 - 25 ng/ml / 0.5 ng/ml |
25 ul |
quantitative |
MTPL |
96 wells |
65,000 |
| PSA,
Total |
EIA3945 |
|
|
|
quantitative |
MTPL |
96 wells |
upon req. |
| PSA,
Total (Prostate Specific Antigen) |
CLA4657 |
30 / 30 / 10 - 15 min. |
0.005 - 100 ng/ml /// 0.002 ng/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
90,000 |
| PTH
Intact (Parathyroid Hormone) |
EIA3645 |
3 hrs |
.9 pg/ml |
human serum |
quantitative |
MTPL |
96 wells |
101,000 |
| PTH
intact (rat) Elisa |
EIA4935 |
3/h/30 min |
25-840 pg/ml /// 1.6 pg/ml |
25 ul serum plasma or cell
culture media |
quantitative |
MTPL |
96 wells |
373,000 |
| PTH-RP
(1-34) (human, rat, mouse) Elisa |
EIA4757 |
2h/ 1h/ 1h RT |
0-100 ng/ml /// - |
50 ul plasma |
quantitative |
MTPL |
96 wells |
177,000 |
| R |
|
|
|
| Rabies
IgG (dog) Ab, virus |
EIA2486 |
|
Positive and Negative Control |
|
|
VET. |
96 wells |
160,000 |
| Rabies
IgM (dog) Ab, virus |
EIA2487 |
|
Positive and Negative Control |
|
qualitative |
VET. |
96 wells |
177,000 |
| Rabies
Virus (dog) Ag, Nucleo |
EIA2490 |
|
Positive and Negative Control |
|
|
VET. |
96 wells |
251,000 |
| Rabies
Virus Ag, Glycoprotein |
EIA2489 |
|
Positive and Negative Control |
|
|
VET. |
96 wells |
251,000 |
| Renin
(active), Elisa |
EIA5125 |
120 / 30 / 15 min |
2.5 - 128 pg/ml /// 1.13 pg/ml |
75 ul plasma (EDTA) |
quantitative |
MTPL |
96 wells |
109,000 |
| Reovirus
Type 3 (guinea pig) EcoElisa |
EIA5018 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Reovirus
Type 3 (guinea pig) EcoElisa |
EIA5019 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Reovirus
Type 3 (hamster) EcoElisa |
EIA5020 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Reovirus
Type 3 (hamster) EcoElisa |
EIA5021 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Reovirus
Type 3 (mouse) EcoElisa |
EIA5014 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Reovirus
Type 3 (mouse) EcoElisa |
EIA5015 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Reovirus
Type 3 (rat) EcoElisa |
EIA5016 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Reovirus
Type 3 (rat) EcoElisa |
EIA5017 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Resistin
(human) |
EIA4194 |
90/60/30 min |
0,16 - 10 ng/ml 0,16 ng/ml |
20 ul serum/plasma bioligical
Media (dilution 1 |
quantitative |
MTPL |
96 wells |
225,000 |
| Resistin
(human) Elisa |
EIA4572 |
60 / 60 / 60 / 10 min |
1 - 50 ng/ml // 0.033 ng/ml |
10 ul serum, plasma and tissue
culture medium |
quantitative |
MTPL |
96 wells |
253,000 |
| Resistin
(human) Elisa |
EIA4945 |
2/h / 2h/ 30 / 30 min |
0.016 - 1 ng/ml /// - |
100 ul plasma, serum, culture
media, tissues ho |
quantitative |
MTPL |
96 wells |
177,000 |
| Resistin
(mouse) |
EIA4283 |
60 / 60 / 30 / 15 min |
0.78 - 50 ng/ml // 0.78 ng/ml |
10 ul serum, plasma, adipocyte
extracts or cell |
quantitative |
MTPL |
96 wells |
225,000 |
| Resistin
(mouse) |
EIA4554 |
60/60/30/10 min. |
1 - 100 ng/ml // 5 pg/ml |
10 ul serum, plasma (EDTA,
citrate) and tissues |
quantitative |
MTPL |
96 wells |
253,000 |
| Resistin
(rat) Elisa |
EIA4550 |
60/60/30/10 min |
0.25 - 20 ng / ml // 0.05ng/ml |
10 ul serum and tissue culture
media |
quantitative |
MTPL |
96 wells |
306,000 |
| Retinol
Binding Protein |
EIA5202 |
|
|
|
qualitative |
MTPL |
96 wells |
114,000 |
| Retinol
binding Protein (RBP) Elisa |
EIA4391 |
1h/ 1h/ 10/20 min. |
1/1 - 33 ug/l // 0.9 ug/l |
20 ul plasma, serum; 100 ul
urine |
quantitative |
MTPL |
96 wells |
282,000 |
| RF IgA
(Rheumatoid Factor), Elisa |
EIA3586 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| RF IgG
(Rheumatoid Factor), Elisa |
EIA3584 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| RF
IgG/IgM/IgA (Rheumatoid Factor Screen)
Elisa |
EIA3583 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| RF IgM
(Rheumatoid Factor) |
EIA2775 |
20, 20, 10 RT |
|
serum, 10 uL |
semi-quant. |
MTPL |
96 wells |
76,000 |
| RF IgM
(Rheumatoid Factor), Elisa |
EIA3585 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| Rib-P,
anti- Elisa |
EIA3582 |
|
|
|
quantitative |
MTPL |
96 wells |
103,000 |
| RNP-70
Kd, anti- Elisa |
EIA3579 |
|
|
|
quantitative |
MTPL |
96 wells |
105,000 |
| Rotavirus/
EDIM (mouse) EcoElisa |
EIA5022 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Rotavirus/
EDIM (mouse) EcoElisa |
EIA5023 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| RSV IgA
(Respiratory syncytial virus) |
EIA3506 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| RSV IgG
(Respiratory syncytial virus) |
EIA3507 |
60 37 min C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| RSV IgM
(Respiratory syncytial virus) |
EIA3508 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
71,000 |
| Rubella
IgG |
EIA1800 |
90 min at RT |
|
serum |
quantitative |
MTPL |
96 wells |
65,000 |
| Rubella
IgG quant. |
EIA3510 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
quantitative |
MTPL |
96 wells |
67,000 |
| Rubella
IgM |
EIA1801 |
90 min at RT |
|
serum |
quantitative |
MTPL |
96 wells |
67,000 |
| Rubella
IgM |
EIA3511 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
67,000 |
| Rubella
IgM CLA |
CLA5197 |
30min 37C / 30 / 15 min. RT |
3 Standards |
10 ul serum |
quantitative |
MTPLL |
96 wells |
71,000 |
| S |
|
|
|
| S100
Elisa (not incl. controls, avail. on req : order EIA4458) |
EIA4556 |
120/60/30 min |
50 - 3500 ng/L // <10 ng/L |
50 uL serum |
quantitative |
MTPL |
96 wells |
517,000 |
| S100A8/S100A9
(mouse/rat) Elisa |
EIA5142 |
60/60/60 min 37 C, 5-15 min RT |
0.25 - 15.6 /// - |
100 ul stool, serum, (plasma,
urine, tissues ex |
quantitative |
MTPL |
96 wells |
401,000 |
| S100B
(human) Elisa |
EIA4555 |
90/90/10 min |
50 - 2000 pg/ml // 5 pg/ml |
60 ul serum, liquor, plasma and
tissue culture |
quantitative |
MTPL |
96 wells |
253,000 |
| S100B
Elisa |
EIA5169 |
120/60/30 min |
100 - 5000 pg/ml /// 10 pg/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
111,000 |
| SALI-TUBES
100 |
SLV4158 |
|
|
|
|
|
100 t. |
56,000 |
| SALI-TUBES
500 |
SLV4157 |
|
|
|
|
|
500 t. |
78,000 |
| Saliva
Control |
SLV4576 |
|
|
|
|
|
3 x 2 ml |
88,000 |
| sApo1/FAS
(human) Elisa |
EIA4854 |
1 hr / 1 hr / 10 min at 37C |
16-1000 pg/mL /// 13.2 pg/mL |
50 ul cell culture, serum,
plasma, other body f |
quantitative |
MTPL |
96 wells |
223,000 |
| sCD23
(human) Elisa |
EIA4833 |
2 hrs / 1 hr / 10 min. at RT |
12.5 - 400 U/mL /// 6.789 U/mL |
100 ul cell culture, serum,
plasma other biol f |
quantitative |
MTPL |
96 wells |
223,000 |
| sCD30
(human) Elisa |
EIA4849 |
3 hrs/ 10 min. at RT |
1.6 - 100 ng/mL /// 0.33 ng//mL |
25 ul cell culture supernatant,
serum, plasma |
quantitative |
MTPL |
96 wells |
223,000 |
| sCD40
(human) Elisa |
EIA4850 |
2 hrs / 1 hr / 10 min at RT |
8 - 500 pg/mL /// 7.92 pg/mL |
50 ul cell culture supernatant,
other body flui |
quantitative |
MTPL |
96 wells |
223,000 |
| sCD40
Ligand (human) Elisa |
EIA4852 |
2 hrs at RT shaking or overnight
at 4C / 10 min |
0.16 - 10 pg/mL /// 0.062 pg/mL |
20 ul cell culture, serum,
plasma |
quantitative |
MTPL |
96 wells |
223,000 |
| sCD40
Ligand (human) high sensitive Elisa |
EIA4851 |
2 hrs / 1 hr / 10 min |
0.08 - 5.0 ng/mL /// 0.01 ng/mL |
20 ul cell culture supernatant,
serum and plasm |
quantitative |
MTPL |
96 wells |
240,000 |
| sCD40
Ligand (mouse) Elisa |
EIA5191 |
120 / 60 / 10 min |
0.31 - 20.0 ng/ml /// 0.14 ng/ml |
50 ul cell culture supernatant,
serum |
quantitative |
MTPL |
96 wells |
204,000 |
| sCD44
(human) Elisa |
EIA4876 |
3 hrs/ 15 min. at RT |
0.12-4ng/m. /// 0.015 ng/mL |
10 ul cell culture supernatant,
other body flui |
quantitative |
MTPL |
96 wells |
223,000 |
| Schistosoma
IgG |
EIA3512 |
10 / 10 / 5 min. |
pos. / neg. control // - |
100 ul serum (diluted 1:40) |
|
|
96 wells |
82,000 |
| Scl-70,
anti- Elisa |
EIA3580 |
|
|
|
quantitative |
MTPL |
96 wells |
99,000 |
| Secretory
IgA (sIgA) Elisa |
EIA4601 |
60 / 60 / 5 - 15 min RT |
22.2 - 600 ng/ml // 13.4 ng/ml |
10 ul saliva + 100 mg stool |
quantitative |
MTPL |
96 wells |
211,000 |
| Sendai
Virus (guinea pig) EcoElisa |
EIA5028 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Sendai
Virus (guinea pig) EcoElisa |
EIA5029 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Sendai
Virus (hamster) EcoElisa |
EIA5030 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Sendai
Virus (hamster) EcoElisa |
EIA5031 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Sendai
Virus (mouse) EcoElisa |
EIA5024 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Sendai
Virus (mouse) EcoElisa |
EIA5025 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
358,000 |
| Sendai
Virus (rat) EcoElisa |
EIA5026 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
49 wells |
204,000 |
| Sendai
Virus (rat) EcoElisa |
EIA5027 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Serotonin |
EIA1300 |
18 hrs |
0.14-33 ng/ml |
plasma or urine |
quantitative |
MTPL |
96 wells |
120,000 |
| Serotonin
FAST Elisa |
EIA5061 |
30 / 15 / 15 m in |
15-2500 ng/ml /// 5 ng/mL |
25 ul serum, urine and platelets |
quantitative |
MTPL |
96 wells |
149,000 |
| Serotonin
Research (ultra sensitive) |
EIA4642 |
30/min/15-20h 2-2C/30/20-30min |
2-333 pg /// 1 pg |
20 ul tissue homogenates,
dialysates and oth. u |
quantitative |
MTPL |
96 wells |
221,000 |
| sE-Selectin
Elisa |
EIA4775 |
2 hrs / 15 min. at RT |
1.6 - 50 ng/ml /// 0.33 ng/mL |
20 uL serum, plasma, cell
culture and other bio |
quantitative |
MTPL |
96 wells |
223,000 |
| sFAS
Ligand (human) Elisa |
EIA4855 |
2 hrs / 1 hr / 10 min. at RT |
0.16 - 10 ng/mL /// 0.07 ng/mL |
50 ul cell culture, serum,
plasma, amniotic flu |
quantitative |
MTPL |
96 wells |
223,000 |
| sGP130/sCD130
(human) Elisa |
EIA4768 |
60/30/10 - 15 min |
56.25 - 1800 pg/mo /// <15 pg/ml |
100 ul cell culture
supernatants, human serum, |
quantitative |
MTPL |
96 wells |
242,000 |
| SHBG
(Sex Hormone Binding Globulin) IEMA |
EIA2996 |
30 / 15 / 12 min |
4 - 260 nmol/l // 0.2 nmol/l |
25 uL serum / plasma |
quantitative |
MTPL |
96 wells |
78,000 |
| sICAM-1
(human) |
EIA4781 |
60 / 10 min |
6.25 - 100 ng/ml - /// 2.17 ng/mL |
10 uL cell cult. supern., serum,
plasma, urine, |
quantitative |
MTPL |
96 wells |
223,000 |
| Simian
Virus 5 (guinea pig) EcoElisa |
EIA5032 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil serum |
qualitative |
VET |
48 wells |
204,000 |
| Simian
Virus 5 (guinea pig) EcoElisa |
EIA5033 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| Simian
Virus 5 (hamster) EcoElisa |
EIA5034 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
232,000 |
| Simian
Virus 5 (hamster) EcoElisa |
EIA5035 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil serum |
qualitative |
VET |
96 wells |
358,000 |
| SLE
(anti-Nucleosomes) Elisa |
EIA3610 |
|
|
|
quantitative |
MTPL |
96 wells |
114,000 |
| sL-selectin
human Elisa |
EIA4875 |
2 hrs/ 15 min. at RT |
0.39-25ng/ml /// 0.19 ng/mL |
5 ul cell culture supernatant,
other body fluid |
quantitative |
MTPL |
96 wells |
223,000 |
| Sm
anti-, Elisa |
EIA3577 |
|
|
|
quantitative |
MTPL |
96 wells |
99,000 |
| Sm IgG |
EIA2784 |
20, 20, 10 RT. |
|
serum, 10 uL |
semi-quant. |
MTPL |
96 wells |
78,000 |
| Sm RNP
IgG |
EIA2785 |
20, 20, 10 RT |
|
serum, 10uL |
semi-quant. |
MTPL |
96 wells |
78,000 |
| Sm RNP,
anti-RNP Elisa |
EIA3578 |
|
|
|
quantitative |
MTPL |
96 wells |
99,000 |
| sp185
(HER-2) human Elisa |
EIA4877 |
2 hrs/ 10 min. at RT |
0.16-10ng/ml /// 0.06 ng//mL |
15 ul cell culture supernatant,
other body flui |
quantitative |
MTPL |
96 wells |
223,000 |
| Sperm
Ab Ig-Typing Elisa |
EIA4878 |
60/60 min 37 C, 30 min RT |
31-250 U/mL /// --- |
5 uL serum |
quantitative |
MTPL |
96 wells |
156,000 |
| Sperm
Antibody |
EIA1826 |
3 hrs. |
62-500 U/ml |
serum |
quantitative |
MTPL |
96 wells |
88,000 |
| Sperm
Antibody |
EIA4249 |
60/60 min 37 C; 30 min. RT |
31 - 250 U/ml /// - |
50ul dil. seminal plasma (dil.
100 ul ejaculate |
quantitative |
MTPL |
96 wells |
88,000 |
| sPJ-selectin
human, Elisa |
EIA4874 |
2 hrs/ 15 min. at RT |
2.19-140 ng/ml /// 1.06 ng/mL |
10 ul cell culture supernatant,
other body flui |
quantitative |
MTPL |
96 wells |
223,000 |
| sRANKL
(free) human Elisa |
EIA4771 |
2h/ 1h/1h/10 min RT |
0.4 - 40 pmol/l /// 0.2pmol/l |
5 ul serum / plasma |
quantitative |
MTPL |
96 wells |
331,000 |
| sRANKL
(total) human Elisa |
EIA4772 |
16h 4/6C; 1h/1h/10min RT |
0.4 - 64 pmol/l /// 0.1pmol/l |
5 ul serum / plasma |
quantitative |
MTPL |
96 wells |
331,000 |
| SS-A
(Ro) IgG |
EIA2782 |
20, 20, 10 RT. |
|
serum, 10 uL |
semi-quant. |
MTPL |
96 wells |
78,000 |
| SS-A
(Ro), anti- Elisa |
EIA3573 |
|
|
|
quantitative |
MTPL |
96 wells |
99,000 |
| SS-A
52, anti- Elisa |
EIA3574 |
|
|
|
quantitative |
MTPL |
96 wells |
111,000 |
| SS-A
60, anti- Elisa |
EIA3575 |
|
|
|
quantitative |
MTPL |
96 wells |
111,000 |
| SSB
(La) IgG |
EIA2783 |
20, 20, 10 RT. |
|
serum, 10 uL |
semi-quant. |
MTPL |
96 wells |
78,000 |
| SS-B
(La), anti- Elisa |
EIA3576 |
|
|
|
quantitative |
MTPL |
96 wells |
99,000 |
| Substance
P (human - rat - mouse) |
EIA1634 |
4 hrs. at RT |
0.02-0.05 ng/ml |
plasma |
quantitative |
MTPL |
96 wells |
177,000 |
| sVCAM-1
human Elisa |
EIA4873 |
2 hrs/ 15 min. at RT |
3.2-100 ng/ml /// 0.59 ng/mL |
10 uL cell culture supernatant,
other body fluid |
quantitative |
MTPL |
96 wells |
223,000 |
| Syphilis
(anti-TP) (double antigen sandwich method) |
EIA4131 |
|
|
|
qualitative |
MTPL |
96 wells |
56,000 |
| Syphilis
(Treponema pallidum) Ab |
EIA3798 |
|
|
|
quantitative |
MTPL |
96 wells |
80,000 |
| Syphilis
(Treponema Pallidum) Elisa |
EIA5218 |
30 / 10 min 37 C |
neg. + pos. control /// no |
50 ul serum or plasma |
qualitative |
MTPL |
96 wells |
59,000 |
| Syphilis
Ab Screen
(min. order 10 kits) |
EIA4405 |
45/45 min. 37 C; 15 min. RT |
pos. / neg. control,
qualit. // 100 % |
10 ul serum; plasma |
qualitative |
MTPL |
192 wells |
95,000 |
| Syphilis
IgG (Treponema Pallidum IgG) |
EIA3517 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Syphilis
IgM (Treponema Pallidum IgM) |
EIA4267 |
60 37C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Syphilis
Screen (Treponema pallidum Screen) |
EIA5054 |
60 / 60 / 30 min at 37 C |
neg., pos. cut-off control /// n.d. |
20 uL serum, plasma |
qualitative |
MTPL |
96 wells |
73,000 |
| Syphilis
Screen IgG/IgM (Treponema Pallidum Screen IgG/IgM) Elisa |
EIA4697 |
60/30/15 min at RT |
pos. / neg./ cut-off
control /// - |
100 ul Serum, Plasma |
qualitative |
MTPL |
96 wells |
76,000 |
| T |
|
|
|
| T-3,
Free |
EIA2385 |
|
|
|
|
|
96 wells |
61,000 |
| T-3,
Total |
EIA1780 |
2 hrs. at RT |
0.2 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
56,000 |
| T-3,
total Elisa |
EIA4569 |
30/30/20 min. at RT |
0.5 - 10.0 ng/ml // 0.1 ng/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
59,000 |
| T-3,
Uptake |
EIA3267 |
60 / 15 min at RT |
15.0 - 46.0 % U / .. |
25 ul serum or plasma |
quantitative |
MTPL |
192 wells |
78,000 |
| T-4
(canine) |
EIA2492 |
|
Positive and Negative Control |
|
|
VET. |
96 wells |
160,000 |
| T-4
Canine (dog) Rapid EIA |
EIA3441 |
|
|
|
|
VET. |
32 wells |
107,000 |
| T-4
feline (cat) Rapid EIA |
EIA3442 |
|
|
|
|
VET. |
32 wells |
107,000 |
| T-4,
free |
CLA4659 |
30 min 27 C / 10/15 min RT |
2 - 120 pg/ml /// 1 pg/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
80,000 |
| T-4,
Free |
EIA2386 |
|
|
|
|
|
96 wells |
61,000 |
| T-4,
Free |
EIA4109 |
|
|
|
quantitative |
MTPL |
192 wells |
75,000 |
| T-4,
Total |
EIA1781 |
1 hr. at RT |
0.4 ug/dl |
serum |
quantitative |
MTPL |
96 wells |
56,000 |
| T-4,
total Elisa |
EIA4568 |
5/80 min. at RT, 10 min at
18-25, 7 min 26-29C, 5 min at |
- / 10 nmol/L |
10 ul serum |
quantitative |
MTPL |
96 wells |
59,000 |
| Taenia
Solium IgG (cysticercosis) |
EIA3513 |
10 / 10 / 5 min. |
pos. / neg. control // 88 % |
100 ul serum (diluted 1:64) |
qualitative |
MTPL |
96 wells |
84,000 |
| TBEV IgG
(tick borne encephalitis virus) (FSME) |
EIA3515 |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
95,000 |
| TBEV IgM
(tick borne encephalitis virus) (FSME) |
EIA3516 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
73,000 |
| Testosterone |
EIA1559 |
75 min. at RT |
0.2-16 ng/ml |
serum, plasma |
quantitative |
MTPL |
96 wells |
61,000 |
| Testosterone |
SLV3013 |
60 / 30 min |
10 - 5000 pg/ml // 1.9 pg/mL |
100 ul saliva |
quantitative |
MTPL |
96 wells |
73,000 |
| Testosterone
(rat) Elisa |
EIA5179 |
60 / 30 min |
0.1 - 25 ng/ml /// 0.066 ng/ml |
10 ul serum/plasma |
quantitative |
MTPL |
96 wells |
177,000 |
| Testosterone
(serum) CLA |
CLA4662 |
min |
|
serum |
quantitative |
MTPL |
96 wells |
65,000 |
| Testosterone,
(Dihydrotestosterone) |
EIA4132 |
|
|
|
quantitative |
MTPL |
96 wells |
76,000 |
| Testosterone,
free |
CLA4660 |
30 min 37 C / 10 - 15 min |
0.25 - 100 pg/ml /// 0.17 pg/ml |
25 ul serum |
quantitative |
MTPL |
96 wells |
80,000 |
| Testosterone,
Free |
EIA2924 |
1 hour @ RT |
0.15 pg/ml |
serum / plasma |
quantitative |
MTPL |
96 wells |
82,000 |
| Testosterone,
Saliva |
CLA4661 |
30 / 30 / 10 - 15 min |
2 - 800 pg/ml /// 1.0 pg/ml |
100 ul saliva |
quantitative |
MTPL |
96 wells |
82,000 |
| Tetanus
toxin IgG (quant.) |
EIA3514 |
60 min 37 C; 30 / 15 min. RT |
2 x pos. control (0.5+5 IU/ml)/
1 x neg. control |
10 ul serum (1+100 diluted) |
quantitative |
MTPL |
96 wells |
69,000 |
| TGF beta
1 (human) (Transforming Growth Factor) |
EIA1864 |
16-24 hrs at 4 C or RT, total
inc.time :7hrs |
20 - 600 pg/ml; 10pg/ml
sensitivity |
serum/plasma |
quantitative |
MTPL |
96 wells |
94,000 |
| TGF beta
2 (human) (Transfornimg Growth Factor) |
EIA2396 |
|
|
|
quantitative |
MTPL |
96 wells |
94,000 |
| ThromboCombo
IgG / IgM |
EIA3883 |
60'RT |
IgG: 0-100U/mL, IgM: 0-100
U/ml --- |
10 ul serum or plasma |
quantitative |
MTPL |
96 wells |
122,000 |
| Thyroglobulin |
EIA4126 |
|
|
|
quantitative |
MTPL |
96 wells |
75,000 |
| Thyroglobulin
Ab |
EIA3708 |
30/15/15/5 min |
0 - 9000 IU/ml / 10 IU/ml |
10 ul serum plasma |
quantitative |
MTPL |
96 wells |
90,000 |
| Thyroglobulin
anti- |
EIA1613 |
2 hrs at 37 C. |
on request |
serum |
quantitative |
MTPL |
96 wells |
101,000 |
| Thyroglobulin
Anti-Thyroglobulin |
EIA4110 |
|
|
|
quantitative |
MTPL |
96 wells |
69,000 |
| Thyroglobulin
Elisa |
EIA3377 |
|
|
|
quantitative |
MTPL |
96 wells |
80,000 |
| Thyroglobulin
IgG |
EIA2792 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
MTPL |
96 wells |
82,000 |
| TIMP-1
Elisa (Tissue Inhibitor of Matrix Metalloproteinase-1) |
EIA3782 |
120/30/30 min RT |
1.56-25 ng/ml < 1ng/ml |
50 uL serum, plasma, buffered
solution, or cell |
quantitative |
MTPL |
192 wells |
314,000 |
| TM-CA125
Elisa |
EIA5072 |
|
|
|
quantitative |
MTPL |
96 wells |
upon req. |
| TM-CA15.3
Elisa |
EIA5068 |
|
|
|
quantitative |
MTPL |
96 wells |
upon req. |
| TM-CA19.9
Elisa |
EIA5069 |
|
|
|
quantitative |
MTPL |
96 wells |
upon req. |
| TM-CA72.4
Elisa |
EIA5071 |
|
|
|
quantitative |
MTPL |
96 wells |
upon req. |
| TM-CYFRA21.1 |
EIA5070 |
60 / 15 min |
3 - 50 ng/ml /// 0.15 ng/ml |
50 ul serum, plasma |
quantitative |
MTPL |
96 wells |
101,000 |
| TNF
(alpha) (rat) |
EIA4774 |
120 / 60 / 15 min |
39 - 2500 pg/ml /// 11.2 pg/ml |
50 ul cell cultures
supernatants, human serum, |
quantitative |
MTPL |
96 wells |
208,000 |
| TNF
alpha (mouse) Elisa |
EIA3158 |
90 / 30 / 30 min |
19.5 - 1250 pg/mL // <3 pg/mL |
50 ul serum, plasma / 100 uL
buffered solution, |
quantitative |
MTPL |
96 wells |
312,000 |
| TNF
alpha (mouse) Elisa |
EIA3167 |
2.5 hrs. in total |
19-2000 pg/ml |
50ul Serum, Plasma |
quantitative |
MTPL |
192 wells |
498,000 |
| TNF
alpha (porcine) |
EIA3186 |
Incubation time: 4 hours |
15.6 - 1000 pg/ml |
50 ul serum, plasma, cell
culture samples + 50 |
quantitative |
MTPL |
96 wells |
344,000 |
| TNF
alpha (porcine) |
EIA3187 |
Incubation time: 4 hours |
15.6 - 1000 pg/ml |
50 ul serum, plasma, cell
culture samples + 50 |
quantitative |
MTPL |
192 wells |
498,000 |
| TNF
alpha (rat) Elisa |
EIA2358 |
2.5 hrs. in total |
15-1000 pg/ml |
50ml Serum, Plasma |
quantitative |
MTPL |
96 wells |
312,000 |
| TNF
alpha (rat) Elisa |
EIA3168 |
2.5 hrs. in total |
15 1000 plg/ml |
50ml Serum, Plasma |
quantitative |
MTPL |
192 wells |
546,000 |
| TNF
alpha Elisa / CE |
EIA4641 |
120/120/30 min |
7-518 pg/ml /// 0.7 pg/ml |
200 ul serum |
quantitative |
MTPL |
96 wells |
196,000 |
| TNF beta
(human) Elisa |
EIA5128 |
4 h / 15 min. |
8 - 1000 pg/mL /// 4.6 pg/ml |
100 ul cell culture supernatant
and serum, plas |
quantitative |
MTPL |
96 wells |
223,000 |
| Toolan's
H-1 Virus (rat) EcoElisa |
EIA5036 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
48 wells |
204,000 |
| Toolan's
H-1 Virus (rat) EcoElisa |
EIA5037 |
30 / 30 / 20 min. |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
qualitative |
VET |
96 wells |
329,000 |
| TORCH
IgM screening (capture) Elisa (w/o CE) (min. order 10 kits) |
EIA5183 |
45 / 45 / (37C) / 15 min RT |
... /// >99.5 % |
10 uL plasma / serum |
qualitative |
MTPL |
96 wells |
122,000 |
| Toxocara
Canis IgG |
EIA3518 |
10 / 10 / 5 min. |
pos. / neg. control // 93.3 % |
100 ul serum (diluted 1:64) |
qualitative |
MTPL |
96 wells |
84,000 |
| Toxoplasma
gondii IgA Elisa |
EIA3683 |
1h/30 min. |
|
serum |
quantitative |
MTPL |
96 wells |
90,000 |
| Toxoplasma
gondii IgG (quantitative) |
EIA3519 |
60 min 37 C; 30 / 15 min. RT |
20 - 200 IU/ml + neg. control |
10 ul serum (1+100 diluted) |
quantitative |
MTPL |
96 wells |
67,000 |
| Toxoplasma
gondii IgM |
CLA5198 |
30min 37C/ 30 / 15 min RT |
3 standards |
10 uL serum |
quantitative |
MTPL |
96 wells |
71,000 |
| Toxoplasma
gondii IgM |
EIA3520 |
60 min 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
76,000 |
| Toxoplasma
IgG (TORCH) |
EIA1798 |
90 min at RT |
|
serum |
quantitative |
MTPL |
96 wells |
65,000 |
| Toxoplasma
IgM (TORCH) |
EIA1799 |
90 min at RT |
|
serum |
quantitative |
MTPL |
96 wells |
67,000 |
| t-PA
(human) Elisa |
EIA5112 |
120 / 15 min. at RT |
16-1000 pg/mL /// 4 pg/mL |
10 ul cell culture supernatant
and serum, plasm |
quantitative |
MTPL |
96 wells |
223,000 |
| TPO
(Thyroid Peroxidas) Anti-TPO |
EIA4114 |
|
|
|
quantitative |
MTPL |
96 wells |
71,000 |
| TPO
(Thyroid Peroxidase) anti- Elisa |
EIA3561 |
30 / 15 / 15 min |
33 - 3000 IU/mL // 5 IU/mL |
10 ul serum / plasma |
quantitative |
MTPL |
96 wells |
90,000 |
| TPO IgG
(Thyroid Peroxidase) |
EIA2791 |
20, 20, 10 RT |
|
serum, 10uL |
qualitative |
MTPL |
96 wells |
82,000 |
| TPS
(CYK18) (Tissue Polypeptide
Specific Ag) (Cytokeratin) Elisa |
EIA2354 |
|
|
|
quantitative |
MTPL |
96 wells |
217,000 |
| TRAIL
(human) Elisa |
EIA4009 |
120/60/30/30 min |
46.8 - 3000 pg/ml - quant. / <20 pg/ml |
100 ul cell extract |
quantitative |
MTPL |
96 wells |
390,000 |
| Transferrin
Receptor (sTfR) human Elisa (Soluble) |
EIA4256 |
60 / 60 min. 30 C; 10 min RT |
0.2 - 10 ug/mll // 0.1 ug/ml |
30 ul serum, plasma and tissued
culture medium |
quantitative |
MTPL |
96 wells |
232,000 |
| Transglutaminase
IgA, anti- |
EIA3611 |
|
|
|
quantitative |
MTPL |
96 wells |
107,000 |
| Transglutaminase
IgG, anti-tissue |
EIA3882 |
30'/15' RT |
1U/ml |
10 ul serum or plasma |
quantitative |
MTPL |
96 wells |
107,000 |
| Transglutaminase
Screen, anti-tissue Elisa |
EIA4464 |
30 / 15 / 15 min |
5 - 200 U/ml // 1 U/ml |
10 ul serum / plasma |
quantitative |
MTPL |
96 wells |
107,000 |
| Tricat
(Adrenalin, Noradrenalin, Dopamine) Elisa |
EIA4634 |
30/20/120/60/40 min |
Adrenalin / Noradrenalin /
Dopamin diff // Urin |
500 ul plasma, 20 ul urine |
quantitative |
MTPL |
96 wells |
289,000 |
| TriCat
Elisa (Adrenaline/Noradrenaline/Dopamine) |
EIA4080 |
30/120/15 min. |
Adr: 10-2560 pg/ml , Noradr:
40-10240 pg/ml, Dop. |
Plasma and Urine |
quantitative |
MTPL |
3 x 96 wells |
365,000 |
| TriCat
Research Elisa (Adren. / Noradren./ Dopamine) |
EIA4891 |
90 min Acylation / 2h 37C/15-20
h 2-8C/20-30min |
0.45 - 45 ng/ml/ 0.9-90ng/ml
(Dopamine) /// 0.3 |
1-750 uL; for various biological
samples types |
quantitative |
MTPL |
3x96 wells |
415,000 |
| Trichinella
spiralis Ab (pig) Elisa |
EIA4838 |
10 / 10 / 10 min |
pos. / neg. control /// / |
swine sera, plasma, shole blood
or tissue fluid |
qualitative |
VET |
96 wells |
84,000 |
| Trichinella
spiralis IgG |
EIA3521 |
10 / 5 / 5 min. |
pos. / neg. control // 96.3 % |
100 ul serum (diluted 1:64) |
qualitative |
MTPL |
96 wells |
82,000 |
| Troponin
I Elisa |
EIA2952 |
|
|
serum |
quantitative |
MTPL |
96 wells |
94,000 |
| Trypsin
Neonate |
EIA1278 |
75 min. at RT |
|
|
quantitative |
MTPL |
192 wells |
124,000 |
| TSH |
CLA4658 |
30 / 10 - 15 min |
0.008 - 25 ulU/ml // 0.002 ulU/ml |
50 ul serum |
quantitative |
MTPL |
96 wells |
80,000 |
| TSH
(Thyroid Stimulating Hormone) |
EIA1782 |
80 min. at RT |
0.2 uIU/ml |
serum |
quantitative |
MTPL |
96 wells |
59,000 |
| TSH
(Thyroid Stimulating Hormone) |
EIA4111 |
|
|
|
quantitative |
MTPL |
192 wells |
75,000 |
| TSH
Elisa |
EIA4171 |
10/90/20 min. RT |
0-15 mlU/l // 0.027 mlU/L |
25 ul serum |
quantitative |
MTPL |
96 wells |
59,000 |
| TSH
receptor Ab Elisa (3rd Generation) |
EIA4834 |
2h / 25 min |
0.4 - 30 units./L /// / |
75 ul serum |
quantitative |
MTPL |
96 wells |
196,000 |
| TSH
Receptor Autoantibody Elisa (TRAb) |
EIA3369 |
2 hrs/20/20/20 min. at RT |
negative/positive control |
100 ul serum |
qualitative |
MTPL |
96 wells |
156,000 |
| TSH
Ultrasensitive |
EIA1790 |
4 hrs. at RT |
0.05 uIU/ml |
serum |
quantitative |
MTPL |
96 wells |
59,000 |
| Tuberculosis
IgA |
EIA4250 |
60 / 30 / 20 min. RT |
ps. / neg. control |
100 ul serum, plasma (diluted
1:101) |
qualitative |
MTPL |
96 wells |
109,000 |
| Tuberculosis
IgG |
EIA4252 |
60 / 30 / 20 min. RT |
pos. / neg. control |
100 ul serum, plasma (diluted
1:101) |
qualitative |
MTPL |
96 wells |
109,000 |
| Tuberculosis
IgG sensitive Elisa |
EIA4508 |
60 / 30 / 20 min. RT |
1 - 150 U/ML /
/ |
100 ul serum, plasma (diluted
1:101) |
quantitative |
MTPL |
96 wells |
109,000 |
| Tuberculosis
IgM |
EIA4251 |
60 / 30 / 20 min. RT |
pos. / neg. control |
100 ul serum, plasma (diluted
1:101) |
qualitative |
MTPL |
96 wells |
109,000 |
| Tumor
Marker Control I (1 vial, 0.5 ml lyophilized) |
CTL4756 |
|
|
|
controls |
|
1 vial |
46,000 |
| Tumor
Marker Control II (1 vial, o.5 ml lyophilized) |
CTL4755 |
|
|
|
|
|
1 vial |
46,000 |
| U |
|
|
|
| UBC
(Urinary Bladder Cancer) Elisa |
EIA2355 |
|
|
urine |
quantitative |
MTPL |
96 wells |
213,000 |
| Ureaplasma
urealyticum IgA |
EIA5098 |
60/30/15 min |
neg., pols cutoff control |
10 uL serum |
qualitative |
MTPL |
96 wells |
80,000 |
| Ureaplasma
urealyticum IgG Elisa |
EIA4623 |
60 / 60 / 20 min at RT |
pos./neg./cut-off control |
10 ul serum, plasma |
qualitative |
MTPL |
96 wells |
65,000 |
| Urinary
Retinol Binding Protein |
EIA5205 |
|
|
|
quantitative |
MTPL |
96 wells |
143,000 |
| Urotensin
II (human) |
EIA3303 |
2 hrs RT |
0 - 100 ng/mL |
Plasma |
qualitative |
MTPL |
96 wells |
194,000 |
| V |
|
|
|
| Varicella
Zoster IgA (VZV) |
EIA3522 |
60 min. 37 C; 30 / 15 min RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
71,000 |
| Varicella
Zoster IgG ( VZV) |
EIA3523 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Varicella
Zoster IgG (VZV) (ref. sera opt., price on req.) |
EIA2808 |
20, 20, 10 RT |
|
serum: 10uL |
qualitative |
MTPL |
96 wells |
73,000 |
| Varicella
Zoster IgM (VZV) |
EIA3524 |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
69,000 |
| Vasopressin
(human) Elisa |
EIA4944 |
2n / 2h/ 1h RT |
0-100 ng/ml /// ... |
50 ul plasma |
quantitative |
MTPL |
96 wells |
177,000 |
| VEGF
(human) Elisa (vascular endothelialgrowth factor) |
EIA4819 |
120 / 60 / 30 min. |
8.2 - 6000 pg/ml /// <5 pg/ml |
100 ul Cell culture
supernatants, plasma and se |
quantitative |
MTPL |
96 wells |
168,000 |
| VEGF ,
sVEGF-1/Receptor 1 (human) Elisa |
EIA4822 |
2hrs / 1 hr/ 20 min. at RT |
0.16 - 10.0 ng/mL /// 0.06 ng/mL |
50 ul Cell Culture, serum,
plasma other biol. f |
quantitative |
MTPL |
96 wells |
223,000 |
| VEGF
human (Vascular Endothelial Growth Factor) |
EIA4631 |
120/60/30 min RT |
23.4 - 1500 pg/mL // <5 pg/mL |
50 ul serum, plasma, buffered
solution, or cell |
quantitative |
MTPL |
192 wells |
498,000 |
| VEGF-C
(human) Elisa |
EIA4825 |
2hrs / 1hr / 10 min. at RT |
46.9-3000 pg/mL /// 12.8 pg/mL |
50 ul cell culture, serum,
plasma other body fl |
quantitative |
MTPL |
96 wells |
223,000 |
| VEGF-C
(rat) Elisa |
EIA5101 |
2hrs/ 1 hr/ 10 min. at RT |
47-3000 pg/mL /// 4pg/mL |
50 ul cell culture supernatant
and serum or oth |
quantitative |
MTPL |
96 wells |
208,000 |
| Visfatin
human Elisa |
EIA4633 |
3/3/3h 37C, 20 min RT |
0.25-32 ng/mL // 100 pg/mL |
serum, plasma, various tissue or
cell cult. sup |
quantitative |
MTPL |
96 wells |
447,000 |
| Visfatin
mouse Elisa |
EIA5086 |
4 C overnight, 1/1h, 30 min. 37
C |
0.5 - 32.00 ng/mL /// 50 pg/mL |
50 uL serum |
quantitative |
MTPL |
96 wells |
525,000 |
| Vitamin
B1 (Thiamin) (old number BIO4880) |
BIO5136 |
24 h at 37 C |
3 - 15 ng/L /// - |
100 ul whole blood |
quantitative |
MTPL |
96 tests |
282,000 |
| Vitamin
B12 |
BIO4883 |
48 h at 37 C |
6 - 54 ng/L /// --- |
100 ul serum |
quantitative |
MTPL |
96 wells |
282,000 |
| Vitamin
B2 (Riboflavin) |
BIO4887 |
48 h at 37 C |
5 - 60 ng/L /// --- |
150 ul serum |
quantitative |
MTPL |
96 wells |
282,000 |
| Vitamin
B6 (Pyridoxin) |
BIO4885 |
48 h at 37 C |
0.36 - 3 ug/L /// --- |
300 ul serum |
quantitative |
MTPL |
96 wells |
282,000 |
| Vitamin
Biotin |
BIO4884 |
48 h at 37 C |
0.02 - 0.18 ug/L /// --- |
50 ul serum |
quantitative |
MTPL |
96 wells |
282,000 |
| Vitamin
C (Ascorbineacid) |
ENZ4888 |
3 h at 37 C / 20 min RT |
1.25 - 80 mg/I /// 0.7 mg/l=L |
200 uL Li-Heparinat-Plasma |
quantitative |
MTPL |
96 wells |
177,000 |
| Vitamin
D binding Protein (VDBP) Elisa |
EIA5088 |
60 / 60 / 10-20 min |
2.2 - 60 ng/ml /// 1.23 ng/ml |
10 ul serum, plasma, urine |
quantitative |
MTPL |
96 wells |
282,000 |
| Vitamin
D, (1.25 Dihydroxy Vit. D) Elisa |
EIA4484 |
overnight 2-8C / 90/60/30 min RT |
4 - 500 pmol/L // 6 pmol/L (2.5 pg/mL) |
500 ul serum, plasma |
quantitative |
MTPL |
96 wells |
527,000 |
| Vitamin
D, 1,25 Dihydroxyvitamin D Elisa |
EIA4193 |
24 hrs |
5.1 - 200 pg/ml /
4.8 pg/ml |
1 ml plasma or serum |
quantitative |
MTPL |
96 wells |
285,000 |
| Vitamin
D, 25 OH EIA |
EIA3153 |
3 hrs/1hr at 4 C/20-30 min. at
RT |
6 standards ( concentration see
via lbels), 2 cont |
50 ul serum/plasma extraction |
quantitative |
MTPL |
96 wells |
194,000 |
| Vitamin
D, 25 OH Vitamin D direct Elisa |
EIA4696 |
60 min 37 C / overnight 8-10 C/
60 min. 20-30 min RT |
6.4 - 250 nmol/L /// 2.0 nmol/l |
20 ul serum / plasma |
quantitative |
MTPL |
96 wells |
209,000 |
| Vitamin
Folic Acid |
BIO4886 |
48 H at 37 C |
0.04 - 0.32 ug/L /// --- |
100 ul serum |
quantitative |
MTPL |
96 wells |
282,000 |
| Vitamin
Niacin |
BIO4882 |
48 h at 37 C |
4 - 40 mg/L /// --- |
100 ul serum |
quantitative |
MTPL |
96 wells |
335,000 |
| VMA
(vanyl mandelic acid) |
EIA1620 |
85 min. at RT |
0.0625-8 ug/ml |
urine |
quantitative |
MTPL |
96 wells |
113,000 |
| W |
|
|
|
| West
Nile IgG Elisa |
EIA4519 |
60/60 min 37 C; 5/10 min RT |
- // - |
4 uL serum (dilution 1:300) |
qualitative |
MTPL |
96 wells |
116,000 |
| Y |
|
|
|
| Yersinia
enterolitica IgA, Elisa |
EIA2566 |
|
|
|
|
|
96 wells |
128,000 |
| Yersinia
enterolitica IgG, Elisa |
EIA2567 |
|
|
|
|
|
96 wells |
128,000 |
| Yersinia
enterolitica IgM, Elisa |
EIA2568 |
|
|
|
|
|
96 wells |
124,000 |
| Z |
|
|
|
| Zeta
Globin Elisa |
EIA5047 |
30 / 30 / 15 min |
neg. + pos. control /// 100 % |
500 uL whole blood |
qualitative |
MTPL |
96 wells |
133,000 |
| Zona
Pellucida Ab Ig-Typing |
EIA3778 |
|
|
|
quantitative |
MTPL |
96 wells |
139,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|